To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene RPL7L1TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
740 representative clones for gene RPL7L1 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
CN333340 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 1 to 509 2 to 510   tiling clone,   510/510
(100 %)
0 diff
(100 %id)
BP872209 embryonal kidney .a 1 to 441 2 to 442       442/447
(98 %)
3 diff
(99.4 %id)
DC364865   .a 1 to 510 2 to 512       512/512
(100 %)
1 diff
(99.9 %id)
DA733776   .a 7 to 633 2 to 629   capped   628/628
(100 %)
9 diff
(98.6 %id)
DC360713   .a 8 to 570 1 to 569       569/569
(100 %)
9 diff
(98.5 %id)
BC036861 Cervix, carcinoma .a 47 to 1819 11 to 1782 N136S L137K K138N M139A L140A ... available from MGC, AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 1772/1772
(100 %)
3 diff
(99.9 %id)
BI255539 cervical carcinoma cell line, cervix .a 48 to 838 1 to 799   available from MGC,   799/854
(93 %)
15 diff
(98.3 %id)
T19140   .a 58 to 309 1 to 251       251/254
(98 %)
5 diff
(98.1 %id)
DC345634 tongue, tumor tissue .a 233 to 811 1 to 579       579/579
(100 %)
1 diff
(99.9 %id)
BG400666 Kidney .a 260 to 1046 1 to 794 L90X F125L S126V G127V V128S ...     794/794
(100 %)
16 diff
(98.0 %id)
BI260699 cervical carcinoma cell line, cervix .a 260 to 862 1 to 604       604/607
(99 %)
8 diff
(98.7 %id)
CD709337 normal nasopharynx .a 266 to 781 16 to 530       515/530
(97 %)
9 diff
(98.4 %id)
DC297720   .a 269 to 827 1 to 559       559/559
(100 %)
0 diff
(100 %id)
DC349314   .a 272 to 843 1 to 573       573/573
(100 %)
1 diff
(99.9 %id)
DC360215   .a 272 to 800 1 to 530       530/531
(99 %)
3 diff
(99.5 %id)
BG024086 duodenal adenocarcinoma, cell line, small intestine .a 273 to 805 1 to 545       545/1245
(43 %)
22 diff
(98.3 %id)
DC332347 hippocampus .a 274 to 796 1 to 523       523/523
(100 %)
0 diff
(100 %id)
BU959247 mixed (pool of 40 RNAs) .a 275 to 1086 1 to 811 H219T L220S S221Q V222W A223P ...     811/814
(99 %)
18 diff
(97.8 %id)
DC297857   .a 276 to 839 1 to 565       565/565
(100 %)
1 diff
(99.9 %id)
DC299578   .a 276 to 820 1 to 545       545/545
(100 %)
1 diff
(99.9 %id)
DC306622 cerebellum .a 276 to 644 1 to 369       369/369
(100 %)
0 diff
(100 %id)
DC324097 brain .a 276 to 847 1 to 572       572/572
(100 %)
0 diff
(100 %id)
DC351214 brain .a 276 to 852 1 to 579       579/579
(100 %)
2 diff
(99.7 %id)
DC351437 brain .a 276 to 841 1 to 566       566/566
(100 %)
0 diff
(100 %id)
DC354936   .a 276 to 832 1 to 557       557/557
(100 %)
0 diff
(100 %id)
BJ991314 hepatoblastoma .a 276 to 858 1 to 583       583/583
(100 %)
0 diff
(100 %id)
DC359751   .a 276 to 836 1 to 561       561/561
(100 %)
0 diff
(100 %id)
CB120709 Liver .a 276 to 822 1 to 547       547/547
(100 %)
0 diff
(100 %id)
DC363427   .a 276 to 825 1 to 550       550/550
(100 %)
0 diff
(100 %id)
DC370496   .a 276 to 816 1 to 541       541/541
(100 %)
1 diff
(99.9 %id)
DC386907   .a 276 to 851 1 to 576       576/576
(100 %)
0 diff
(100 %id)
DC296179 synovial membrane tissue from rheumatioidarthritis .a 276 to 825 1 to 551       551/551
(100 %)
1 diff
(99.9 %id)
DC393666 colon, tumor tissue .a 276 to 856 1 to 581       581/581
(100 %)
0 diff
(100 %id)
DC417093 trachea .a 276 to 882 1 to 606       606/606
(100 %)
1 diff
(99.9 %id)
CN333341 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 277 to 841 9 to 573       565/573
(98 %)
6 diff
(99.0 %id)
DA611479   .a 277 to 784 2 to 510   capped   509/509
(100 %)
3 diff
(99.5 %id)
DA793000 brain .a 277 to 749 2 to 474   capped   473/473
(100 %)
0 diff
(100 %id)
DA819198   .a 277 to 827 2 to 552   capped   551/551
(100 %)
1 diff
(99.9 %id)
DA925688 small intestine .a 277 to 841 2 to 566   capped   565/565
(100 %)
1 diff
(99.9 %id)
DB194577 trachea .a 277 to 848 2 to 573   capped   572/572
(100 %)
0 diff
(100 %id)
BY800291 eye .a 278 to 893 1 to 616       616/616
(100 %)
0 diff
(100 %id)
BF540866 hypernephroma, Kidney .a 278 to 877 1 to 602       602/607
(99 %)
12 diff
(98.1 %id)
BU933019 mixed (pool of 40 RNAs) .a 279 to 1037 1 to 763       763/763
(100 %)
11 diff
(98.6 %id)
CR746949 leiomyosarcoma, uterus .a 280 to 787 8 to 515       508/515
(98 %)
6 diff
(98.9 %id)
BI552087 brain, hippocampus .a 280 to 977 1 to 698       698/698
(100 %)
5 diff
(99.3 %id)
BI457621 brain, hypothalamus .a 280 to 986 1 to 709       709/709
(100 %)
10 diff
(98.6 %id)
BI598752 brain, hypothalamus .a 280 to 1071 1 to 800       800/802
(99 %)
19 diff
(97.7 %id)
BI599373 brain, hypothalamus .a 280 to 955 1 to 687       687/688
(99 %)
30 diff
(95.7 %id)
CD697592 normal nasopharynx .a 282 to 813 24 to 555       532/555
(95 %)
8 diff
(98.6 %id)
DB500240 hypothalamus .a 282 to 767 1 to 485       485/485
(100 %)
2 diff
(99.6 %id)
DB502523 hypothalamus .a 282 to 978 1 to 694       694/696
(99 %)
5 diff
(99.3 %id)
DB506642 hypothalamus .a 282 to 947 1 to 664       664/664
(100 %)
3 diff
(99.6 %id)
DA652628   .a 282 to 877 2 to 597   capped   596/596
(100 %)
1 diff
(99.9 %id)
BM750420 Ascites, stomach .a 282 to 861 1 to 580       580/580
(100 %)
0 diff
(100 %id)
DA007887   .a 283 to 833 2 to 552   capped   551/551
(100 %)
1 diff
(99.9 %id)
DA278639 corpus callosum .a 283 to 814 2 to 533   capped   532/532
(100 %)
0 diff
(100 %id)
DA498676 brain .a 283 to 848 2 to 567   capped   566/566
(100 %)
0 diff
(100 %id)
DA565933 heart .a 283 to 851 2 to 570   capped   569/569
(100 %)
0 diff
(100 %id)
DA604216   .a 283 to 766 2 to 486   capped   485/490
(98 %)
2 diff
(99.6 %id)
DA604684   .a 283 to 786 2 to 506   capped   505/506
(99 %)
4 diff
(99.3 %id)
DA664852   .a 283 to 852 2 to 571   capped   570/570
(100 %)
0 diff
(100 %id)
DA665629   .a 283 to 838 2 to 558   capped   555/557
(99 %)
2 diff
(99.7 %id)
DA707019   .a 283 to 868 2 to 588   capped   587/587
(100 %)
1 diff
(99.9 %id)
DA791602 brain .a 283 to 796 2 to 515   capped   514/514
(100 %)
1 diff
(99.9 %id)
DA815422   .a 283 to 857 2 to 576   capped   575/575
(100 %)
1 diff
(99.9 %id)
DA883158   .a 283 to 853 2 to 572   capped   571/571
(100 %)
0 diff
(100 %id)
DA892817 skeletal muscle .a 283 to 1057 2 to 775   capped   774/784
(98 %)
12 diff
(98.5 %id)
DA907299   .a 283 to 837 2 to 557   capped   556/556
(100 %)
1 diff
(99.9 %id)
DA939681 Spleen .a 283 to 876 2 to 596   capped   595/595
(100 %)
1 diff
(99.9 %id)
DB230685 trachea .a 283 to 872 2 to 591   capped   590/590
(100 %)
1 diff
(99.9 %id)
BX281674 leiomyosarcoma, uterus .a 284 to 771 1 to 488       488/488
(100 %)
0 diff
(100 %id)
CB112751 Liver .a 284 to 822 1 to 539       539/539
(100 %)
4 diff
(99.3 %id)
BJ994865 hepatoblastoma .a 285 to 884 1 to 600       600/600
(100 %)
0 diff
(100 %id)
TI_45211069   .a 285 to 1071 92 to 886       795/888
(89 %)
21 diff
(97.7 %id)
TI_45211503   .a 285 to 955 93 to 774       682/775
(88 %)
29 diff
(96.3 %id)
CB126887 Liver .a 285 to 821 1 to 537       537/537
(100 %)
1 diff
(99.9 %id)
DA005429   .a 286 to 862 2 to 578   capped   577/577
(100 %)
0 diff
(100 %id)
DA007123   .a 286 to 844 2 to 561   capped   560/560
(100 %)
1 diff
(99.9 %id)
DA143885 amygdala .a 286 to 865 2 to 582   capped   581/581
(100 %)
1 diff
(99.9 %id)
DA246061 brain .a 286 to 838 2 to 554   capped   553/555
(99 %)
2 diff
(99.7 %id)
DA381769 thalamus .a 286 to 843 11 to 568   capped   558/558
(100 %)
0 diff
(100 %id)
DA436346 tongue, tumor tissue .a 286 to 859 2 to 576   capped   575/575
(100 %)
1 diff
(99.9 %id)
DA441660 tongue, tumor tissue .a 286 to 847 2 to 564   capped   563/563
(100 %)
1 diff
(99.9 %id)
DA483275 brain .a 286 to 1004 2 to 720   capped   719/719
(100 %)
5 diff
(99.4 %id)
DA515924 brain .a 286 to 837 2 to 553   capped   552/552
(100 %)
0 diff
(100 %id)
DA529165 brain .a 286 to 890 2 to 606   capped   605/605
(100 %)
0 diff
(100 %id)
DA539278 Kidney .a 286 to 873 2 to 589   capped   588/588
(100 %)
0 diff
(100 %id)
DA574605   .a 286 to 865 2 to 581   capped   580/580
(100 %)
1 diff
(99.9 %id)
BU539904 mixed (pool of 40 RNAs) .a 286 to 1006 1 to 725       725/733
(98 %)
9 diff
(98.8 %id)
DA613966   .a 286 to 861 2 to 577   capped   576/576
(100 %)
0 diff
(100 %id)
TI_44171713   .a 286 to 977 87 to 778       692/778
(88 %)
6 diff
(99.3 %id)
DA710795   .a 286 to 843 2 to 559   capped   558/558
(100 %)
0 diff
(100 %id)
DB199888 trachea .a 286 to 800 2 to 517   capped   516/516
(100 %)
1 diff
(99.9 %id)
DB283269 uterus .a 286 to 837 2 to 553   capped   552/552
(100 %)
0 diff
(100 %id)
DB283812 uterus .a 286 to 837 2 to 553   capped   552/552
(100 %)
0 diff
(100 %id)
CR746648 leiomyosarcoma, uterus .a 287 to 769 8 to 490       483/490
(98 %)
9 diff
(98.2 %id)
DB471701 hippocampus .a 288 to 746 1 to 459       459/459
(100 %)
0 diff
(100 %id)
CA453761 mixed (pool of 40 RNAs) .a 288 to 994 1 to 713       713/814
(87 %)
10 diff
(98.8 %id)
CD697009 normal nasopharynx .a 289 to 832 15 to 558       544/558
(97 %)
8 diff
(98.6 %id)
CD685714 normal nasopharynx .a 291 to 938 23 to 670       648/670
(96 %)
6 diff
(99.2 %id)
BU958796 mixed (pool of 40 RNAs) .a 291 to 975 1 to 691       691/773
(89 %)
18 diff
(97.7 %id)
DA025618   .a 292 to 860 2 to 569   capped   568/568
(100 %)
2 diff
(99.7 %id)
DA446014 tongue, tumor tissue .a 292 to 854 2 to 564   capped   563/563
(100 %)
1 diff
(99.9 %id)
DA472684   .a 292 to 857 2 to 567   capped   566/566
(100 %)
0 diff
(100 %id)
DW432300 Liver .a 292 to 546 12 to 266       255/266
(95 %)
5 diff
(98.2 %id)
CB959431 Pooled-Glandular .a 292 to 970 1 to 690       690/748
(92 %)
28 diff
(96.3 %id)
DA743700   .a 292 to 825 2 to 535   capped   534/534
(100 %)
0 diff
(100 %id)
DN997869 breast cancer, Mammary gland (cancer tissue) .a 292 to 830 9 to 546       538/546
(98 %)
6 diff
(99.0 %id)
CB113617 brain .a 294 to 571 1 to 278       278/278
(100 %)
1 diff
(99.7 %id)
BC058020 Pooled, 40 cell lines .a 294 to 1310 5 to 1021   available from MGC, AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 1017/1017
(100 %)
1 diff
(100.0 %id)
DA492483 brain .a 294 to 869 2 to 577   capped   576/576
(100 %)
0 diff
(100 %id)
BU963833 mixed (pool of 40 RNAs) .a 294 to 970 1 to 681       681/705
(96 %)
23 diff
(96.8 %id)
DA454932 tongue, tumor tissue .a 295 to 842 2 to 550   capped   549/551
(99 %)
2 diff
(99.7 %id)
DA454999 tongue, tumor tissue .a 295 to 875 2 to 582   capped   581/581
(100 %)
0 diff
(100 %id)
BG251075 adenocarcinoma, cell line, Liver .a 295 to 1021 1 to 731       731/1171
(62 %)
13 diff
(98.9 %id)
DA678989   .a 295 to 845 2 to 552   capped   551/551
(100 %)
0 diff
(100 %id)
DA702172   .a 295 to 843 2 to 549   capped   548/548
(100 %)
1 diff
(99.9 %id)
DA710325   .a 295 to 842 2 to 549   capped   548/548
(100 %)
0 diff
(100 %id)
DA752309   .a 295 to 874 2 to 581   capped   580/580
(100 %)
0 diff
(100 %id)
DA878686 Prostate .a 295 to 857 2 to 564   capped   563/563
(100 %)
0 diff
(100 %id)
DA886945   .a 295 to 861 2 to 568   capped   567/567
(100 %)
0 diff
(100 %id)
DA907285   .a 295 to 785 2 to 494   capped   493/493
(100 %)
2 diff
(99.6 %id)
DA996553   .a 295 to 822 2 to 530   capped   529/529
(100 %)
3 diff
(99.5 %id)
DB012209 esophageal, tumor tissue .a 295 to 862 2 to 569   capped   568/568
(100 %)
0 diff
(100 %id)
DB012995 esophageal, tumor tissue .a 295 to 866 2 to 573   capped   572/572
(100 %)
1 diff
(99.9 %id)
DA020780   .a 297 to 865 2 to 570   capped   569/569
(100 %)
0 diff
(100 %id)
CD684422 normal nasopharynx .a 297 to 929 32 to 664       633/664
(95 %)
7 diff
(99.0 %id)
DA494321 brain .a 297 to 867 2 to 572   capped   571/571
(100 %)
0 diff
(100 %id)
BG179600 adenocarcinoma, cell line, Prostate .a 297 to 1026 1 to 722       722/723
(99 %)
9 diff
(98.8 %id)
BI089871 cervix .a 297 to 1052 1 to 758       758/758
(100 %)
4 diff
(99.5 %id)
BI257833 cervical carcinoma cell line, cervix .a 297 to 1052 1 to 759       759/764
(99 %)
8 diff
(99.0 %id)
BM012128 brain, neuroblastoma, cell line .a 297 to 1108 1 to 812       812/813
(99 %)
12 diff
(98.6 %id)
CB134520 Liver .a 297 to 961 1 to 665       665/665
(100 %)
1 diff
(99.9 %id)
DA689278   .a 297 to 846 2 to 551   capped   550/550
(100 %)
0 diff
(100 %id)
BM832601 stomach .a 297 to 827 1 to 531       531/531
(100 %)
0 diff
(100 %id)
AA247976   .a 298 to 541 1 to 241       241/242
(99 %)
7 diff
(97.2 %id)
DA032587   .a 298 to 850 2 to 554   capped   553/553
(100 %)
0 diff
(100 %id)
DA048928   .a 298 to 837 2 to 541   capped   540/540
(100 %)
0 diff
(100 %id)
DA072816 cerebellum .a 298 to 879 2 to 584   capped   583/583
(100 %)
1 diff
(99.9 %id)
DA233292 brain .a 298 to 869 2 to 573   capped   572/572
(100 %)
0 diff
(100 %id)
DA497178 brain .a 298 to 879 2 to 583   capped   582/582
(100 %)
0 diff
(100 %id)
DA504478 brain .a 298 to 868 2 to 572   capped   571/571
(100 %)
0 diff
(100 %id)
DA552388   .a 298 to 877 2 to 581   capped   580/580
(100 %)
0 diff
(100 %id)
DA552752   .a 298 to 858 2 to 562   capped   561/561
(100 %)
0 diff
(100 %id)
DA568912 whole embryo, mainly head .a 298 to 1180 2 to 884   capped   883/884
(99 %)
6 diff
(99.4 %id)
DA580889   .a 298 to 851 2 to 555   capped   554/554
(100 %)
0 diff
(100 %id)
BI224392 cervical carcinoma cell line, cervix .a 298 to 1000 1 to 703       703/706
(99 %)
1 diff
(99.9 %id)
TI_59381328   .a 298 to 1108 110 to 920       811/812
(99 %)
11 diff
(98.7 %id)
DA691867   .a 298 to 853 2 to 557   capped   556/556
(100 %)
0 diff
(100 %id)
DA765954 tongue .a 298 to 874 2 to 578   capped   577/577
(100 %)
0 diff
(100 %id)
DA888712   .a 298 to 877 2 to 581   capped   580/580
(100 %)
2 diff
(99.7 %id)
DA897802 skeletal muscle .a 298 to 863 2 to 567   capped   566/566
(100 %)
1 diff
(99.9 %id)
DA942505 Spleen .a 298 to 879 2 to 583   capped   582/582
(100 %)
0 diff
(100 %id)
DB145306 thymus .a 298 to 866 2 to 574   capped   573/573
(100 %)
5 diff
(99.2 %id)
DB196001 trachea .a 298 to 856 2 to 560   capped   559/559
(100 %)
1 diff
(99.9 %id)
DB202979 trachea .a 298 to 878 2 to 582   capped   581/581
(100 %)
0 diff
(100 %id)
DB207358 trachea .a 298 to 904 2 to 608   capped   607/607
(100 %)
1 diff
(99.9 %id)
DA490821 brain .a 302 to 862 9 to 569   capped   561/561
(100 %)
1 diff
(99.9 %id)
EL736979 mixed .a 303 to 998 1 to 693       693/693
(100 %)
5 diff
(99.3 %id)
CN333326 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 305 to 1066 12 to 775       764/775
(98 %)
3 diff
(99.7 %id)
BU170468 eye, retinoblastoma .a 305 to 1006 11 to 716       706/833
(84 %)
7 diff
(99.2 %id)
CR748986 melanotic melanoma, skin .a 306 to 806 11 to 511       501/511
(98 %)
0 diff
(100 %id)
BM459324 lymph, lymphoma, cell line .a 306 to 1022 1 to 723       723/941
(76 %)
28 diff
(97.1 %id)
BM546784 ovary (pool of 3) .a 307 to 1051 8 to 762       755/1191
(63 %)
13 diff
(99.0 %id)
CX785330 human embryonic stem cells .a 307 to 1127 1 to 821       821/821
(100 %)
0 diff
(100 %id)
CB118349 Liver .a 307 to 775 1 to 469       469/469
(100 %)
1 diff
(99.8 %id)
CB143474 Liver .a 307 to 764 1 to 458       458/458
(100 %)
1 diff
(99.8 %id)
BQ229541 melanotic melanoma, skin .a 308 to 1114 1 to 817       817/886
(92 %)
12 diff
(98.7 %id)
BQ055415 lymph, lymphoma, cell line .a 309 to 1185 1 to 877   AAA   877/997
(87 %)
10 diff
(99.0 %id)
BG747274 adenocarcinoma cell line, colon .a 310 to 968 1 to 676       676/676
(100 %)
32 diff
(95.3 %id)
CX788381 human embryonic stem cells .a 312 to 1129 1 to 818   tiling clone,   818/818
(100 %)
0 diff
(100 %id)
CX788621 human embryonic stem cells .a 312 to 1120 1 to 809       809/809
(100 %)
0 diff
(100 %id)
BF980860 duodenal adenocarcinoma, cell line, small intestine .a 313 to 1018 26 to 723       698/962
(72 %)
27 diff
(97.2 %id)
BQ935294 large cell carcinoma, lung .a 313 to 1233 1 to 929       929/937
(99 %)
27 diff
(97.2 %id)
DA438952 tongue, tumor tissue .a 314 to 902 2 to 590   capped   589/589
(100 %)
4 diff
(99.4 %id)
BU430650 lymph .a 314 to 724 1 to 408       411/415
(99 %)
10 diff
(97.6 %id)
BG419857 Kidney, renal cell adenocarcinoma .a 314 to 844 1 to 530       530/530
(100 %)
4 diff
(99.3 %id)
DN990072 brain, whole brain .a 314 to 968 1 to 653       653/653
(100 %)
7 diff
(99.0 %id)
BF527675 anaplastic oligodendroglioma with 1p/19qloss, brain .a 316 to 1059 1 to 732       732/935
(78 %)
18 diff
(98.1 %id)
BQ220859 melanotic melanoma, skin .a 316 to 1170 1 to 874       874/885
(98 %)
26 diff
(97.1 %id)
AA373729 lung .a 317 to 587 16 to 286       271/290
(93 %)
4 diff
(98.7 %id)
AA242924 brain, neuroepithelial cells .a 317 to 718 1 to 401       401/401
(100 %)
1 diff
(99.8 %id)
BE302718 melanotic melanoma, skin .a 317 to 935 12 to 630       619/630
(98 %)
12 diff
(98.1 %id)
BE409626 choriocarcinoma, placenta .a 317 to 1006 25 to 710       686/783
(87 %)
23 diff
(97.1 %id)
BG390473 embryonal carcinoma, cell line, testis .a 317 to 1000 7 to 691       685/1120
(61 %)
23 diff
(98.0 %id)
BG747221 adenocarcinoma cell line, colon .a 317 to 1085 1 to 766       766/766
(100 %)
3 diff
(99.7 %id)
BQ218773 epithelioid carcinoma, Pancreas .a 317 to 732 10 to 424       415/1220
(34 %)
25 diff
(98.0 %id)
BQ881963 lymph, lymphoma, cell line .a 317 to 835 9 to 527       519/1128
(46 %)
17 diff
(98.5 %id)
CB118672 Liver .a 317 to 929 8 to 620       613/620
(98 %)
0 diff
(100 %id)
DA721725   .a 317 to 662 3 to 348   capped   346/347
(99 %)
0 diff
(100 %id)
CV569960 cornea, eye .a 317 to 937 7 to 627       621/627
(99 %)
0 diff
(100 %id)
TI_1948230569   .a 317 to 521 152 to 356       205/247
(82 %)
0 diff
(100 %id)
CN333334 embryonic stem cells, cell lines H1, H7, andH9 .a 318 to 920 1 to 604       604/614
(98 %)
6 diff
(99.1 %id)
AA376451 lung .a 320 to 633 1 to 317       317/327
(96 %)
8 diff
(97.6 %id)
CN333344 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 320 to 840 1 to 521       521/521
(100 %)
0 diff
(100 %id)
BE409385 choriocarcinoma, placenta .a 320 to 1039 8 to 716       709/723
(98 %)
26 diff
(96.5 %id)
CN333333 embryonic stem cells, DMSO-treated H9 cellline .a 321 to 608 1 to 288       288/288
(100 %)
2 diff
(99.4 %id)
CN333336 embryonic stem cells, cell lines H1, H7, andH9 .a 321 to 938 1 to 618       618/618
(100 %)
1 diff
(99.9 %id)
CN333338 embryonic stem cells, DMSO-treated H9 cellline .a 321 to 1041 1 to 721       721/721
(100 %)
0 diff
(100 %id)
BM836487 Ascites, stomach .a 322 to 715 1 to 394       394/394
(100 %)
0 diff
(100 %id)
CX761161 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .a 323 to 987 1 to 662       662/869
(76 %)
30 diff
(96.6 %id)
BM913015 amelanotic melanoma, cell line, skin .a 324 to 1050 1 to 728       728/1061
(68 %)
4 diff
(99.7 %id)
BE410739 choriocarcinoma, placenta .a 327 to 972 42 to 687       646/692
(93 %)
11 diff
(98.5 %id)
BE884954 leiomyosarcoma, uterus .a 328 to 1031 1 to 699       699/864
(80 %)
26 diff
(97.0 %id)
CF136707 lymph .a 335 to 776 8 to 449       442/449
(98 %)
7 diff
(98.5 %id)
BE779964 eye, retinoblastoma .a 335 to 1052 1 to 720       720/1052
(68 %)
24 diff
(97.8 %id)
TI_154165869   .a 335 to 803 80 to 548       469/470
(99 %)
1 diff
(99.8 %id)
CN333339 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 339 to 889 1 to 551       551/551
(100 %)
3 diff
(99.5 %id)
BM310105 insulinoma, Pancreas .a 341 to 900 8 to 567       560/572
(97 %)
15 diff
(97.4 %id)
BE780121 eye, retinoblastoma .a 341 to 686 1 to 351       351/358
(98 %)
9 diff
(97.5 %id)
BF439670 pooled .a 348 to 727 681 to 302       380/681
(55 %)
3 diff
(99.6 %id)
BM796464 Ascites, stomach .a 423 to 886 11 to 474       464/474
(97 %)
6 diff
(98.8 %id)
AA095635   .a 425 to 584 1 to 159       159/186
(85 %)
3 diff
(98.4 %id)
AW410661 muscle, rhabdomyosarcoma .a 431 to 882 20 to 471       452/471
(95 %)
8 diff
(98.4 %id)
BM474986 duodenal adenocarcinoma, cell line, small intestine .a 437 to 942 1 to 510   AAA   510/1170
(43 %)
24 diff
(98.0 %id)
CN333325 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 451 to 736 1 to 286       286/286
(100 %)
0 diff
(100 %id)
TI_1948230570   .a 605 to 1042 564 to 127       438/465
(94 %)
0 diff
(100 %id)
BE889093 leiomyosarcoma, uterus .a 823 to 1529 1 to 710       710/710
(100 %)
4 diff
(99.5 %id)
CU450960 epidermis .a 894 to 1620 739 to 13     Submitted on the opposite strand 727/739
(98 %)
1 diff
(99.9 %id)
BE207536 melanotic melanoma, skin .a 936 to 1473 538 to 1       538/538
(100 %)
0 diff
(100 %id)
DB162253 thymus .a 963 to 1549 2 to 588   tiling clone, capped   587/589
(99 %)
1 diff
(99.9 %id)
BG683227 brain, neuroblastoma, cell line .a 1036 to 1495 1 to 467       467/832
(56 %)
12 diff
(98.6 %id)
DA644475   .a 1039 to 1621 2 to 585   capped   584/585
(99 %)
6 diff
(99.0 %id)
DA157660 amygdala .a 1069 to 1631 2 to 564   capped   563/563
(100 %)
2 diff
(99.7 %id)
BQ053476 blood, natural killer cells, cell line .a 1086 to 2078 1 to 1004       1004/1110
(90 %)
50 diff
(95.5 %id)
CF127386 Chondrosarcoma Lung Metastasis cell lines, lung .a 1097 to 1815 1 to 717       717/741
(96 %)
3 diff
(99.6 %id)
DA082883 cerebellum .a 1112 to 1661 2 to 552   capped   551/551
(100 %)
3 diff
(99.5 %id)
AA635150 lung, lung carcinoma .a 1116 to 1470 355 to 1       355/355
(100 %)
0 diff
(100 %id)
AI538075 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .a 1133 to 1472 339 to 1       339/339
(100 %)
6 diff
(98.3 %id)
BU170059 embryonal carcinoma, cell line, testis .a 1139 to 1999 1 to 864       864/864
(100 %)
13 diff
(98.5 %id)
DA697432   .a 1153 to 1631 2 to 480   capped   479/479
(100 %)
8 diff
(98.4 %id)
EB360748 eye, lens .a 1154 to 1812 672 to 15   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 658/658
(100 %)
4 diff
(99.4 %id)
CA412069 Chondrosarcoma Grade II, Left Pelvis .a 1155 to 1816 681 to 19   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 663/663
(100 %)
2 diff
(99.7 %id)
DA046820   .a 1177 to 1911 2 to 736   capped   735/746
(98 %)
2 diff
(99.8 %id)
CN417903 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 1193 to 1642 1 to 451       451/451
(100 %)
6 diff
(98.7 %id)
BG402817 bladder, transitional cell papilloma, cell line .a 1221 to 1817 1 to 599       599/622
(96 %)
8 diff
(98.8 %id)
BF770847 epid_tumor .a 1242 to 1774 544 to 12     Submitted on the opposite strand 533/544
(97 %)
0 diff
(100 %id)
BF770848 epid_tumor .a 1250 to 1776 527 to 1     Submitted on the opposite strand 527/527
(100 %)
8 diff
(98.5 %id)
DB355486 whole embryo, mainly head .a 1269 to 1812 544 to 1       544/546
(99 %)
7 diff
(98.8 %id)
DA474933   .a 1305 to 1814 2 to 512   capped   511/511
(100 %)
2 diff
(99.7 %id)
BE891577 melanotic melanoma, skin .a 1328 to 2104 1 to 777       777/780
(99 %)
28 diff
(96.5 %id)
BG024073 duodenal adenocarcinoma, cell line, small intestine .a 1328 to 1777 1 to 451       451/701
(64 %)
11 diff
(98.5 %id)
DB330744 skeletal muscle .a 1346 to 1816 471 to 1       471/471
(100 %)
1 diff
(99.8 %id)
BU857793 adenocarcinoma, cell line, breast .a 1381 to 2095 1 to 716       716/935
(76 %)
5 diff
(99.5 %id)
AI146907 senescent fibroblast .a 1408 to 1812 410 to 6       405/410
(98 %)
0 diff
(100 %id)
BU533091 mixed (pool of 40 RNAs) .a 1410 to 1817 1 to 408       408/444
(91 %)
3 diff
(99.4 %id)
BY999575   .a 1424 to 1817 1 to 394     Submitted on the opposite strand 394/396
(99 %)
2 diff
(99.5 %id)
BF805227 colon_ins .a 1427 to 1644 218 to 2     Submitted on the opposite strand 217/218
(99 %)
0 diff
(100 %id)
BF806145 colon_ins .a 1427 to 1644 218 to 2     Submitted on the opposite strand 217/218
(99 %)
0 diff
(100 %id)
AI261637 Kidney .a 1439 to 1812 377 to 2       376/377
(99 %)
0 diff
(100 %id)
BQ219197 epithelioid carcinoma, Pancreas .a 1444 to 1816 1 to 374   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 374/374
(100 %)
2 diff
(99.5 %id)
AI697408 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .a 1456 to 1816 375 to 14   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 362/362
(100 %)
4 diff
(98.9 %id)
AI472335 pooled .a 1460 to 1816 377 to 21   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 357/357
(100 %)
1 diff
(99.8 %id)
AA583922 larynx .a 1479 to 1817 339 to 1       339/339
(100 %)
1 diff
(99.8 %id)
CN417904 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 1485 to 2117 13 to 645       633/645
(98 %)
6 diff
(99.1 %id)
BE500961.
matches multiple genes
pooled germ cell tumors .a 1488 to 1807 321 to 2     also hits gene LOC220906 320/460
(69 %)
0 diff
(100 %id)
BF974577 B-cells, primary B-cells from tonsils (cell line) .a 1491 to 2251 1 to 761       761/1147
(66 %)
22 diff
(98.1 %id)
BG398168 B-cells, primary B-cells from tonsils (cell line) .a 1491 to 2277 1 to 785       785/931
(84 %)
15 diff
(98.4 %id)
BM456187 lymph, lymphoma, cell line .a 1494 to 2254 1 to 775       775/913
(84 %)
31 diff
(96.7 %id)
BE703152.
matches multiple genes
nervous_normal .a 1500 to 1782 296 to 13     also hits gene LOC220906 284/296
(95 %)
0 diff
(100 %id)
CN417906 embryonic stem cells, DMSO-treated H9 cellline .a 1500 to 2123 1 to 624       624/626
(99 %)
4 diff
(99.4 %id)
BQ069801 brain, neuroblastoma, cell line .a 1500 to 2181 1 to 684       684/1059
(64 %)
6 diff
(99.5 %id)
CF137822 lymph .a 1513 to 1614 8 to 109       102/109
(93 %)
6 diff
(94.5 %id)
BQ054830 lymph, lymphoma, cell line .a 1518 to 2177 1 to 661   tiling clone,   661/1115
(59 %)
3 diff
(99.8 %id)
BQ061015 lymph, lymphoma, cell line .a 1518 to 2180 1 to 664       664/1093
(60 %)
6 diff
(99.5 %id)
AI475070 anaplastic oligodendroglioma, brain .a 1519 to 1807 292 to 3       290/292
(99 %)
0 diff
(100 %id)
BF835281 head_neck .a 1522 to 1846 342 to 18     Submitted on the opposite strand 325/342
(95 %)
0 diff
(100 %id)
BE161361 head_neck .a 1526 to 1835 310 to 1     Submitted on the opposite strand 310/310
(100 %)
2 diff
(99.4 %id)
CB137925 Liver .a 1557 to 1857 1 to 301       301/301
(100 %)
2 diff
(99.4 %id)
CB999123 Pooled-Skin .a 1562 to 2202 1 to 650       650/771
(84 %)
15 diff
(98.1 %id)
BM929861.
matches multiple genes
eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .a 1571 to 1871 1 to 301   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base), also hits gene LOC220906 301/301
(100 %)
2 diff
(99.4 %id)
DA750428   .a 1577 to 2151 2 to 576   capped   575/575
(100 %)
0 diff
(100 %id)
DB178834 kidney, tumor tissue .a 1584 to 2113 2 to 532   capped   531/531
(100 %)
3 diff
(99.5 %id)
N46146 melanocyte .a 1601 to 1951 1 to 355       355/355
(100 %)
6 diff
(98.4 %id)
BF313115 brain, neuroblastoma .a 1609 to 2239 1 to 621       621/821
(75 %)
18 diff
(97.9 %id)
BF313960 brain, neuroblastoma .a 1609 to 2259 1 to 648       648/682
(95 %)
8 diff
(98.9 %id)
BE312884 brain, neuroblastoma .a 1629 to 2270 1 to 639       639/643
(99 %)
9 diff
(98.7 %id)
BG577093 breast, mammary adenocarcinoma, cell line .a 1653 to 2356 1 to 703       703/703
(100 %)
27 diff
(96.2 %id)
BE272023 adenocarcinoma cell line, ovary .a 1660 to 2275 1 to 615       615/615
(100 %)
22 diff
(96.5 %id)
BE742691 adenocarcinoma cell line, ovary .a 1661 to 2202 1 to 541       541/542
(99 %)
13 diff
(97.7 %id)
DA913476   .a 1662 to 2216 2 to 557   capped   556/556
(100 %)
4 diff
(99.3 %id)
CV340030.
matches multiple genes
breast .a 1690 to 1973 1 to 292     also hits gene LOC220906 292/292
(100 %)
23 diff
(92.2 %id)
BG476716 melanotic melanoma, skin .a 1703 to 2383 1 to 686       686/867
(79 %)
35 diff
(96.0 %id)
CN417905 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 1734 to 2358 1 to 625       625/625
(100 %)
11 diff
(98.3 %id)
DA073713 cerebellum .a 1747 to 2307 2 to 563   capped   562/562
(100 %)
7 diff
(98.8 %id)
DA605969   .a 1748 to 2261 2 to 516   tiling clone, capped   515/517
(99 %)
5 diff
(99.1 %id)
CB127410 cervix, Uterine .a 1749 to 2188 1 to 440       440/440
(100 %)
4 diff
(99.1 %id)
CB105734 Liver .a 1749 to 2280 1 to 532       532/532
(100 %)
12 diff
(97.8 %id)
CB105756 Liver .a 1749 to 2112 1 to 364       364/364
(100 %)
2 diff
(99.5 %id)
CB105765 Liver .a 1749 to 2098 1 to 350       350/350
(100 %)
0 diff
(100 %id)
CB105797 Liver .a 1749 to 2195 1 to 447       447/447
(100 %)
5 diff
(98.9 %id)
DB123063 thymus .a 1756 to 2225 2 to 472   capped   471/471
(100 %)
10 diff
(97.9 %id)
BG748474 eye, normal pigmented retinal epithelium .a 1772 to 2484 1 to 713       713/715
(99 %)
7 diff
(99.1 %id)
CN414401 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 1818 to 2267 1 to 450       450/451
(99 %)
9 diff
(98.1 %id)
BU553570 ovary, teratocarcinoma, cell line .a 1853 to 2640 1 to 795   tiling clone,   795/909
(87 %)
11 diff
(98.8 %id)
DB207092 trachea .a 1867 to 2339 2 to 475   capped   474/474
(100 %)
4 diff
(99.2 %id)
BQ064290 lymph, lymphoma, cell line .a 2007 to 2593 1 to 591       591/1146
(51 %)
33 diff
(97.2 %id)
CA439161 lung, Lung Focal Fibrosis .a 2049 to 2750 3 to 705   AAA Submitted on the opposite strand 703/705
(99 %)
6 diff
(99.2 %id)
BG251668 adenocarcinoma, cell line, Liver .a 2053 to 2684 1 to 631       631/941
(67 %)
14 diff
(98.6 %id)
BQ649118 hepatocellular carcinoma, cell line, Liver .a 2077 to 2723 13 to 666       654/1003
(65 %)
22 diff
(97.9 %id)
DB035094 testis .a 2077 to 2628 2 to 551   capped   550/550
(100 %)
14 diff
(97.5 %id)
BM912053 amelanotic melanoma, cell line, skin .a 2146 to 2807 1 to 666   tiling clone,   666/1224
(54 %)
24 diff
(98.1 %id)
BX374684 Neuroblastoma Cot 10-normalized .a 2149 to 2942 1 to 794   tiling clone,   794/794
(100 %)
6 diff
(99.3 %id)
BP432454   .a 2156 to 2382 1 to 227       227/227
(100 %)
8 diff
(96.5 %id)
BI333536 cervical carcinoma cell line, cervix .a 2164 to 2829 24 to 690       667/691
(96 %)
14 diff
(98.0 %id)
BF342474 brain, glioblastoma with EGFR amplification .a 2182 to 2825 1 to 638       638/640
(99 %)
20 diff
(96.9 %id)
BJ991315 hepatoblastoma .a 2773 to 3312 540 to 1   tiling clone,   540/540
(100 %)
0 diff
(100 %id)
AA232226 brain, neuroepithelial cells .a 2936 to 3303 368 to 1       368/368
(100 %)
11 diff
(97.1 %id)
DB365758   .a 3235 to 3774 539 to 1   tiling clone,   539/545
(98 %)
15 diff
(97.3 %id)
N36875 melanocyte .a 3267 to 3774 514 to 1       514/580
(88 %)
17 diff
(97.1 %id)
BJ994866 hepatoblastoma .a 3287 to 3692 407 to 1   tiling clone,   407/407
(100 %)
1 diff
(99.8 %id)
DC385495 skeletal muscle .b 1 to 815 2 to 812 F205L G235V E236N R237A I238S ... tiling clone,   812/814
(99 %)
12 diff
(98.6 %id)
BM083766 melanotic melanoma, skin .b 7 to 801 23 to 823 W140X G178X K179G F180S G181L ...     799/823
(97 %)
14 diff
(98.3 %id)
BM461762 leiomyosarcoma, uterus .b 7 to 896 1 to 894 exact     894/898
(99 %)
13 diff
(98.6 %id)
CR986420 T-Lymphocytes .b 11 to 840 1 to 832 exact     832/838
(99 %)
5 diff
(99.5 %id)
AK291949   .b 12 to 963 1 to 952 exact     952/952
(100 %)
0 diff
(100 %id)
BC073890 Eye, retinoblastoma .b 16 to 1290 1 to 1275 exact tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) 1275/1275
(100 %)
1 diff
(100.0 %id)
NM_198486.2   .b 16 to 1290 1 to 1275 exact RefSeq, AAA Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) 1275/1275
(100 %)
1 diff
(100.0 %id)
BM479954 eye, retinoblastoma .b 17 to 983 1 to 979 K18I R20P     979/1112
(88 %)
39 diff
(96.5 %id)
CX867420 embryonic stem .b 17 to 837 1 to 821 exact fully sequenced,   821/821
(100 %)
0 diff
(100 %id)
CR983711 T-Lymphocytes .b 17 to 836 1 to 823 N220X K226X E227G M228D T230H ...     823/823
(100 %)
5 diff
(99.4 %id)
BQ719860 sympathetic trunk .b 19 to 850 1 to 843 I9S P10L L11W V12F P13Q ...     843/868
(97 %)
16 diff
(98.2 %id)
CN333327 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 23 to 805 1 to 783       783/785
(99 %)
5 diff
(99.4 %id)
BU194634 melanotic melanoma, skin .b 23 to 841 1 to 831       831/894
(92 %)
10 diff
(98.9 %id)
CX784082 human embryonic stem cells .b 25 to 816 1 to 792       792/792
(100 %)
0 diff
(100 %id)
DR156074 human embryonic stem cells differentiated toan early endodermal cell type .b 31 to 857 1 to 827       827/827
(100 %)
4 diff
(99.6 %id)
DR159579 human embryonic stem cells differentiated toan early endodermal cell type .b 31 to 858 1 to 828       828/828
(100 %)
4 diff
(99.6 %id)
BG675447 skin .b 33 to 864 10 to 842       833/842
(98 %)
8 diff
(99.1 %id)
CN333329 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .b 35 to 792 8 to 765       758/765
(99 %)
0 diff
(100 %id)
AL543509 placenta, Placenta Cot 25-normalized .b 35 to 999 1 to 954       954/954
(100 %)
11 diff
(98.9 %id)
BM474253 eye, retinoblastoma .b 35 to 1042 14 to 1021       1011/1024
(98 %)
29 diff
(97.2 %id)
BG577004 breast, mammary adenocarcinoma, cell line .b 39 to 822 1 to 784       784/785
(99 %)
7 diff
(99.2 %id)
BQ935967 large cell carcinoma, lung .b 43 to 935 45 to 940       896/978
(91 %)
20 diff
(98.0 %id)
BQ270896 insulinoma, Pancreas .b 59 to 636 8 to 585       578/585
(98 %)
6 diff
(99.0 %id)
BE618240 eye, retinoblastoma .b 61 to 823 1 to 749       749/888
(84 %)
17 diff
(98.1 %id)
CN333331 embryonic stem cells, cell lines H1, H7, andH9 .b 117 to 843 1 to 727       727/727
(100 %)
0 diff
(100 %id)
BG574489 breast, mammary adenocarcinoma, cell line .b 315 to 867 15 to 580       566/921
(61 %)
23 diff
(97.6 %id)
BE621677 epithelioid carcinoma, Pancreas .b 385 to 1278 941 to 46       894/999
(89 %)
16 diff
(98.4 %id)
BE618775 eye, retinoblastoma .b 391 to 1241 855 to 1       855/901
(94 %)
36 diff
(96.1 %id)
BQ070504 brain, neuroblastoma, cell line .b 417 to 552 1 to 136       955/1028
(92 %)
29 diff
(97.2 %id)
BQ270651 insulinoma, Pancreas .b 711 to 1307 597 to 1   tiling clone,   597/597
(100 %)
0 diff
(100 %id)
CX867339 embryonic stem .b 807 to 1311 510 to 1   fully sequenced,   510/510
(100 %)
5 diff
(99.1 %id)
DC426526 skeletal muscle .b 825 to 1291 467 to 1       467/467
(100 %)
2 diff
(99.6 %id)
TI_154152077   .c 1 to 512 81 to 593   tiling clone,   513/550
(93 %)
20 diff
(96.4 %id)
BQ062041 lymph, lymphoma, cell line .c 105 to 1101 1 to 1006   tiling clone,   1006/1018
(98 %)
29 diff
(97.2 %id)
BQ065208 lymph, lymphoma, cell line .c 264 to 1062 1 to 811   tiling clone,   811/1025
(79 %)
27 diff
(97.4 %id)
BG164697 hypernephroma, cell line, Kidney .c 372 to 964 1 to 591       591/897
(65 %)
7 diff
(99.3 %id)
BF962631 nervous_normal .c 686 to 972 1 to 287   tiling clone,   287/288
(99 %)
1 diff
(99.7 %id)
AA181617   .c 705 to 911 1 to 213       213/215
(99 %)
9 diff
(95.9 %id)
TI_149312536   .d 1 to 712 819 to 107 I185V tiling clone, AAA   713/915
(77 %)
4 diff
(99.6 %id)
BM978105 lung .d 10 to 712 721 to 19 I185V AAA   703/703
(100 %)
1 diff
(99.9 %id)
AW243124 Kidney .d 29 to 717 690 to 4       687/694
(98 %)
10 diff
(98.6 %id)
AW302793 invasive adenocarcinoma, lung .d 224 to 722 20 to 517   tiling clone, Submitted on the opposite strand 498/518
(96 %)
12 diff
(97.7 %id)
AI369840 anaplastic oligodendroglioma, brain .d 255 to 716 462 to 1   tiling clone,   462/462
(100 %)
1 diff
(99.8 %id)
BU072616 Pancreas, Purified pancreatic islet .e 1 to 644 1 to 644 E171G tiling clone,   644/644
(100 %)
1 diff
(99.9 %id)
BC064519 Duodenum, adenocarcinoma .f 1 to 1686 1 to 1686 exact tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 1686/1686
(100 %)
2 diff
(99.9 %id)
BM480341 duodenal adenocarcinoma, cell line, small intestine .f 2 to 541 1 to 541   available from MGC,   541/1144
(47 %)
15 diff
(98.7 %id)
DA020426   .f 280 to 859 2 to 582   capped   581/581
(100 %)
1 diff
(99.9 %id)
DA300354 hippocampus .f 289 to 859 2 to 572   capped   571/571
(100 %)
0 diff
(100 %id)
DA378686 thalamus .f 292 to 870 2 to 580   capped   579/579
(100 %)
0 diff
(100 %id)
DA236646 brain .f 295 to 841 2 to 548   capped   547/547
(100 %)
1 diff
(99.9 %id)
DA439269 tongue, tumor tissue .f 295 to 844 2 to 551   capped   550/550
(100 %)
1 diff
(99.9 %id)
DA707027   .f 295 to 745 2 to 453   capped   452/452
(100 %)
1 diff
(99.8 %id)
DA933590 Spleen .f 295 to 860 2 to 567   capped   566/568
(99 %)
1 diff
(99.9 %id)
DA936081 Spleen .f 295 to 871 2 to 578   capped   577/577
(100 %)
0 diff
(100 %id)
DB117062 thymus .f 295 to 832 2 to 539   capped   538/538
(100 %)
0 diff
(100 %id)
DB122348 thymus .f 295 to 873 2 to 580   capped   579/579
(100 %)
0 diff
(100 %id)
BM465426 eye, retinoblastoma .f 314 to 1276 16 to 989 E121G E126X C142V F144L H145S ...     974/1049
(92 %)
37 diff
(96.5 %id)
CB114513 Liver .f 314 to 888 8 to 582       575/582
(98 %)
0 diff
(100 %id)
DN989369 brain, whole brain .f 314 to 884 25 to 596       572/596
(95 %)
6 diff
(99.0 %id)
BM698608 eye, fetal eyes .f 315 to 776 14 to 475     Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 462/475
(97 %)
7 diff
(98.6 %id)
CN333330 embryonic stem cells, DMSO-treated H9 cellline .f 318 to 847 1 to 530       530/530
(100 %)
0 diff
(100 %id)
BE893949 melanotic melanoma, skin .f 322 to 1137 1 to 818       818/902
(90 %)
43 diff
(95.3 %id)
CN333332 embryonic stem cells, cell lines H1, H7, andH9 .f 536 to 1193 13 to 670 exact     658/670
(98 %)
0 diff
(100 %id)
BM476971 leiomyosarcoma, uterus .f 536 to 1345 12 to 832 D18Y A23G E29*     821/1150
(71 %)
42 diff
(96.4 %id)
BM804151 eye, retinoblastoma .f 558 to 1536 11 to 1007 exact     997/1080
(92 %)
43 diff
(96.1 %id)
BQ216078 embryonal carcinoma, cell line, testis .f 657 to 1345 147 to 845       699/828
(84 %)
31 diff
(96.3 %id)
BX442210 brain, fetal brain .f 698 to 1594 1 to 896       896/896
(100 %)
1 diff
(99.9 %id)
DA683329   .f 825 to 1342 2 to 519   capped   518/518
(100 %)
0 diff
(100 %id)
AA159887 Pancreas .f 846 to 1253 1 to 419       419/419
(100 %)
18 diff
(95.8 %id)
AW503755 lymph .f 860 to 1264 8 to 412       405/412
(98 %)
7 diff
(98.4 %id)
TI_154159779   .f 860 to 1344 84 to 567       484/484
(100 %)
2 diff
(99.6 %id)
BP423454 small intestine .f 861 to 1356 1 to 496     Submitted on the opposite strand 496/496
(100 %)
3 diff
(99.4 %id)
DA571203 whole embryo, mainly head .f 1065 to 1904 2 to 833   tiling clone, capped   832/842
(98 %)
12 diff
(98.6 %id)
BU736245 eye, fetal eyes .f 1285 to 1686 420 to 19   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 402/402
(100 %)
1 diff
(99.8 %id)
AA160754 Pancreas .f 1289 to 1685 398 to 1       398/405
(98 %)
15 diff
(96.3 %id)
BQ069158 brain, neuroblastoma, cell line .f 1364 to 2295 1 to 939       939/1020
(92 %)
41 diff
(96.0 %id)
BM554577 amelanotic melanoma, cell line, skin .f 1366 to 1991 23 to 647       625/660
(94 %)
6 diff
(99.1 %id)
BM912527 amelanotic melanoma, cell line, skin .f 1366 to 1996 11 to 641       631/1113
(56 %)
12 diff
(99.0 %id)
BU618512 Cell Line, Chondrosarcoma .f 1421 to 2126 28 to 731     Submitted on the opposite strand 704/731
(96 %)
6 diff
(99.2 %id)
CX786312 human embryonic stem cells .f 1440 to 2174 1 to 733       733/733
(100 %)
3 diff
(99.6 %id)
BX470847   .f 1442 to 1991 1 to 550       550/550
(100 %)
11 diff
(98.0 %id)
BG036786 adenocarcinoma, cell line, Prostate .f 1506 to 1960 292 to 741       450/960
(46 %)
24 diff
(97.5 %id)
BM449637 melanotic melanoma, skin .f 1554 to 2007 1 to 453       453/459
(98 %)
8 diff
(98.3 %id)
BQ434630 eye, retinoblastoma .f 1595 to 2398 1 to 813   tiling clone,   813/833
(97 %)
31 diff
(96.3 %id)
BF680093 Prostate .f 1678 to 1994 316 to 1     Submitted on the opposite strand 316/339
(93 %)
3 diff
(99.2 %id)
BI044191 ovary .f 1684 to 1902 222 to 2       221/222
(99 %)
0 diff
(100 %id)
BF798891 colon_ins .f 1693 to 2026 341 to 8     Submitted on the opposite strand 334/348
(95 %)
0 diff
(100 %id)
AA460786   .f 1715 to 2144 1 to 430   fully sequenced,   430/430
(100 %)
3 diff
(99.4 %id)
BG178582 adenocarcinoma, cell line, Prostate .f 1785 to 2497 1 to 705   tiling clone,   705/935
(75 %)
16 diff
(98.3 %id)
BQ712352 Spleen .f 1808 to 2719 1 to 923   tiling clone,   923/929
(99 %)
41 diff
(95.6 %id)
TI_154045232   .f 1822 to 2618 875 to 89   tiling clone, AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 787/965
(81 %)
16 diff
(98.4 %id)
DA784922 brain .f 1825 to 2406 2 to 584   capped   583/583
(100 %)
4 diff
(99.4 %id)
DA707461   .f 1826 to 2389 2 to 566   capped   565/565
(100 %)
3 diff
(99.5 %id)
DA946749 Spleen .f 1839 to 2395 2 to 559   capped   558/558
(100 %)
2 diff
(99.7 %id)
DB358035 whole embryo, mainly head .f 2044 to 2609 564 to 1       564/571
(98 %)
20 diff
(96.5 %id)
AA460352   .f 2114 to 2617 504 to 1   fully sequenced,   504/504
(100 %)
4 diff
(99.3 %id)
DC297575   .g 1 to 516 1 to 516 exact     516/516
(100 %)
0 diff
(100 %id)
AK299816 brain .g 1 to 1294 1 to 1294 exact tiling clone,   1294/1294
(100 %)
2 diff
(99.9 %id)
DC377110 brain .g 1 to 483 1 to 483 exact     483/483
(100 %)
0 diff
(100 %id)
BJ996783 hepatoblastoma .g 4 to 443 1 to 439       439/439
(100 %)
0 diff
(100 %id)
DC360435   .g 16 to 582 1 to 567 L128P     567/567
(100 %)
2 diff
(99.7 %id)
BQ267129 insulinoma, Pancreas .g 60 to 363 8 to 311       304/311
(97 %)
6 diff
(98.1 %id)
CN277738 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .g 414 to 902 1 to 489       489/636
(76 %)
0 diff
(100 %id)
BU955177 mixed (pool of 40 RNAs) .g 421 to 770 1 to 349       349/404
(86 %)
2 diff
(99.6 %id)
CN333345 embryonic stem cells, DMSO-treated H9 cellline .g 473 to 1190 9 to 726       718/726
(98 %)
6 diff
(99.2 %id)
CN333328 embryonic stem cells, DMSO-treated H9 cellline .g 476 to 1182 1 to 708   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 708/708
(100 %)
2 diff
(99.8 %id)
DA911043   .g 480 to 1041 2 to 565   capped   564/564
(100 %)
3 diff
(99.5 %id)
BM999009 lung, Lung Focal Fibrosis .g 498 to 1182 703 to 19   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 685/685
(100 %)
0 diff
(100 %id)
BI043780 ovary .g 522 to 859 1 to 337       337/337
(100 %)
13 diff
(96.2 %id)
EB361614 eye, lens .g 529 to 1138 610 to 1       610/611
(99 %)
1 diff
(99.9 %id)
BU191219 ductal carcinoma, cell line, Pancreas .g 532 to 916 1 to 385       385/389
(98 %)
1 diff
(99.8 %id)
BG393873 embryonal carcinoma, cell line, testis .g 548 to 1195 1 to 649       649/694
(93 %)
7 diff
(99.0 %id)
AA373932 lung .g 553 to 1031 1 to 485       485/492
(98 %)
17 diff
(96.6 %id)
BG939204 Bone, Hip .g 598 to 1206 610 to 1       610/610
(100 %)
4 diff
(99.4 %id)
BI043763 ovary .g 616 to 808 1 to 193       193/193
(100 %)
9 diff
(95.4 %id)
BI044217.
matches multiple genes
ovary .g 616 to 891 1 to 276     also hits gene RPL7P21 276/276
(100 %)
4 diff
(98.6 %id)
AW512401 lymph node, lymphoma, follicular mixed small and largecell .g 627 to 1185 559 to 1       559/559
(100 %)
0 diff
(100 %id)
DB344153.
matches multiple genes
thymus .g 637 to 1182 546 to 1     also hits gene rotiya 546/546
(100 %)
0 diff
(100 %id)
BF797173 lymph, lymphoma, cell line .g 645 to 1207 1 to 562       562/976
(57 %)
9 diff
(99.1 %id)
T03024.
matches multiple genes
  .g 662 to 1071 410 to 1   tiling clone, also hits gene RPL7P21 410/410
(100 %)
6 diff
(98.6 %id)
BQ272393 insulinoma, Pancreas .g 663 to 1198 536 to 1   tiling clone,   536/536
(100 %)
0 diff
(100 %id)
AI887265 serous papillary carcinoma, high grade, 2pooled tumors, uterus .g 676 to 1182 507 to 1       507/507
(100 %)
14 diff
(97.3 %id)
BF362912.
matches multiple genes
nervous_normal .g 692 to 862 170 to 1   tiling clone, also hits gene florja, RPL7P21 170/174
(97 %)
7 diff
(96.0 %id)
DB540446 hippocampus .g 696 to 1182 1 to 487     Submitted on the opposite strand 487/487
(100 %)
2 diff
(99.6 %id)
AA604497 adrenal adenoma, adrenal gland .g 697 to 1148 450 to 1       450/450
(100 %)
7 diff
(98.5 %id)
AA633266 colon, colon tumor RER+ .g 703 to 1180 476 to 1       476/476
(100 %)
5 diff
(99.0 %id)
AI283090 placenta .g 704 to 1185 482 to 1       482/482
(100 %)
2 diff
(99.6 %id)
CA941255 Pancreas, Purified pancreatic islet .g 706 to 1181 476 to 1       476/476
(100 %)
0 diff
(100 %id)
AW272763 colon, moderately-differentiated adenocarcinoma .g 711 to 1184 474 to 1       474/474
(100 %)
3 diff
(99.4 %id)
AW473546 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .g 720 to 1182 463 to 1       463/463
(100 %)
1 diff
(99.8 %id)
AL042113 testis .g 740 to 1285 1 to 545   tiling clone,   545/545
(100 %)
7 diff
(98.8 %id)
AW675110 cervical carcinoma cell line, cervix .g 756 to 1182 1 to 427   fully sequenced, AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 427/427
(100 %)
0 diff
(100 %id)
BM310365 insulinoma, Pancreas .g 759 to 1144 386 to 1       386/386
(100 %)
0 diff
(100 %id)
CB122000 Liver .g 762 to 1182 440 to 20   AAA Submitted on the opposite strand 421/421
(100 %)
0 diff
(100 %id)
BM994983 Chondrosarcoma, Left Pubic Bone .g 763 to 1182 438 to 19   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 420/420
(100 %)
0 diff
(100 %id)
BM672762.
matches multiple genes
eye, optic nerve .g 788 to 1199 411 to 1     also hits gene RPL7P21 411/411
(100 %)
2 diff
(99.6 %id)
BQ337002 marrow .g 790 to 904 128 to 14       115/142
(80 %)
0 diff
(100 %id)
BQ337043.
matches multiple genes
marrow .g 790 to 904 117 to 3     also hits gene RPL7P21 115/133
(86 %)
0 diff
(100 %id)
BQ353602.
matches multiple genes
head_neck .g 805 to 991 215 to 30     also hits gene RPL7P21 186/218
(85 %)
0 diff
(100 %id)
AA569743   .g 842 to 1186 347 to 4       344/347
(99 %)
0 diff
(100 %id)
AI370475   .g 862 to 1182 349 to 29   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 321/321
(100 %)
2 diff
(99.4 %id)
AA533408 normal prostatic epithelial cells, Prostate .g 878 to 1182 1 to 305   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 305/305
(100 %)
5 diff
(98.4 %id)
CN302467 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .g 879 to 1182 1 to 304   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 304/304
(100 %)
1 diff
(99.7 %id)
BG483735 lung .g 879 to 1206 1 to 328       328/642
(51 %)
6 diff
(99.1 %id)
AW673949 cervical carcinoma cell line, cervix .g 996 to 1183 188 to 1   fully sequenced, Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 188/188
(100 %)
0 diff
(100 %id)
BJ996784 hepatoblastoma .g 1260 to 1729 470 to 1   tiling clone,   470/470
(100 %)
0 diff
(100 %id)
BI597578 brain, hypothalamus .h 1 to 968 1 to 973 L112S I113S R114V Q115S L116* tiling clone,   973/1027
(94 %)
60 diff
(94.2 %id)
DB040544 testis .h 3 to 564 2 to 563   tiling clone, capped   562/562
(100 %)
1 diff
(99.9 %id)
DA025534   .h 4 to 574 2 to 572   capped   571/571
(100 %)
1 diff
(99.9 %id)
DA114379 cerebellum .h 5 to 546 2 to 543   capped   542/542
(100 %)
2 diff
(99.7 %id)
DA448794 tongue, tumor tissue .h 6 to 562 2 to 558   capped   557/557
(100 %)
0 diff
(100 %id)
DW433501 Liver .h 6 to 250 18 to 262       245/262
(93 %)
6 diff
(97.8 %id)
TI_45209503   .h 6 to 968 93 to 1060 L112S I113S R114V Q115S L116*     968/1114
(86 %)
62 diff
(94.5 %id)
DA714577   .h 7 to 564 2 to 560   capped   559/559
(100 %)
1 diff
(99.9 %id)
DA977864 synovial membrane tissue from rheumatioidarthritis .h 7 to 562 2 to 557   capped   556/556
(100 %)
1 diff
(99.9 %id)
DA996698   .h 7 to 539 2 to 534   capped   533/533
(100 %)
0 diff
(100 %id)
DA543357   .h 8 to 572 2 to 566   capped   565/565
(100 %)
1 diff
(99.9 %id)
DB283778 uterus .h 8 to 555 2 to 549   capped   548/548
(100 %)
0 diff
(100 %id)
DB282431 uterus .h 10 to 560 2 to 552   capped   551/551
(100 %)
0 diff
(100 %id)
DT218898 brain .h 18 to 681 1 to 664 G49E     664/664
(100 %)
1 diff
(99.9 %id)
BM541798 leiomyosarcoma, uterus .h 20 to 884 1 to 869   tiling clone,   869/1059
(82 %)
6 diff
(99.5 %id)
BQ221512 large cell carcinoma, lung .h 25 to 802 1 to 784 P14R     784/832
(94 %)
11 diff
(98.7 %id)
CR978680 T-Lymphocytes .h 29 to 798 1 to 770   tiling clone,   770/770
(100 %)
0 diff
(100 %id)
BM472501 embryonal carcinoma, cell line, testis .h 30 to 875 1 to 858   tiling clone,   858/1026
(83 %)
15 diff
(98.6 %id)
CX781752 human embryonic stem cells .i 1 to 793 9 to 801 exact tiling clone,   793/793
(100 %)
0 diff
(100 %id)
DC365733   .j 1 to 535 1 to 535 exact tiling clone,   535/535
(100 %)
2 diff
(99.7 %id)
BQ777869 Pancreas, Purified pancreatic islet .j 13 to 583 4 to 574 exact     571/574
(99 %)
0 diff
(100 %id)
BQ777064.
matches multiple genes
Pancreas, Purified pancreatic islet .j 13 to 533 4 to 524 exact   Suspected internal deletion, this clone was ignored, also hits gene RPL7P21 521/524
(99 %)
0 diff
(100 %id)
BX415798.
matches multiple genes
thymus .j 444 to 1369 1 to 921   tiling clone, also hits gene blawybu 921/921
(100 %)
28 diff
(97.0 %id)
BQ778172.
matches multiple genes
Pancreas, Purified pancreatic islet .j 608 to 1061 454 to 1     Suspected internal deletion, this clone was ignored, also hits gene RPL7P21 454/454
(100 %)
1 diff
(99.8 %id)
DA759730   .k 1 to 540 2 to 541 exact tiling clone, capped   540/540
(100 %)
0 diff
(100 %id)
DA017299 adrenal gland .l 1 to 489 2 to 490 exact tiling clone, capped   489/489
(100 %)
2 diff
(99.6 %id)
DA833971 placenta .m 1 to 732 2 to 733   tiling clone, capped   732/734
(99 %)
2 diff
(99.8 %id)
DA571803 whole embryo, mainly head .m 858 to 1403 2 to 547   tiling clone, capped   546/546
(100 %)
2 diff
(99.7 %id)
DA296393 hippocampus .m 859 to 1426 2 to 570   capped   569/569
(100 %)
2 diff
(99.7 %id)
AL135490 melanoma (MeWo cell line) .m 868 to 1478 1 to 611   tiling clone,   611/611
(100 %)
0 diff
(100 %id)
BX500441 Liver .m 909 to 1433 1 to 525       525/525
(100 %)
3 diff
(99.5 %id)
BX500435 Liver .m 911 to 1327 22 to 438       417/438
(95 %)
6 diff
(98.7 %id)
BQ708148 Spleen .m 960 to 1483 1 to 525   tiling clone,   525/973
(53 %)
9 diff
(99.1 %id)
DA828113 placenta .m 1782 to 2406 2 to 628   tiling clone, capped Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 627/632
(99 %)
12 diff
(98.2 %id)
BF245358 brain, glioblastoma .m 1798 to 2200 1 to 399       399/399
(100 %)
8 diff
(98.0 %id)
EL954431 eyeball .m 1821 to 2127 21 to 327       307/327
(93 %)
6 diff
(98.2 %id)
AK098059 liver, tumor tissue .m 1837 to 3728 1 to 1892   available from FLJ,   1892/1892
(100 %)
22 diff
(98.9 %id)
DB181484 liver, tumor tissue .m 1838 to 2324 2 to 488   capped   487/487
(100 %)
16 diff
(96.8 %id)
BM463097 melanotic melanoma, skin .m 1867 to 2430 25 to 594       570/1127
(50 %)
23 diff
(98.0 %id)
BE094844 breast .m 1880 to 2023 1 to 142       142/142
(100 %)
2 diff
(98.6 %id)
AA376446 lung .m 1924 to 2093 1 to 171       171/171
(100 %)
4 diff
(97.7 %id)
DA820849 pericardium .m 1946 to 2511 2 to 568   capped   567/567
(100 %)
12 diff
(97.9 %id)
DB009539 colon, tumor tissue .m 1946 to 2220 2 to 276   capped   275/275
(100 %)
4 diff
(98.6 %id)
BQ062824 lymph, lymphoma, cell line .m 1959 to 2591 33 to 669       637/1210
(52 %)
27 diff
(97.8 %id)
BM091179 Fetal Pancreas (4 Pooled Donors, 18 - 20weeks, Stratagene #738023) .m 1991 to 2499 11 to 520       510/520
(98 %)
6 diff
(98.9 %id)
CA848574 Pancreas, Purified pancreatic islet .m 1997 to 2486 1 to 490       490/490
(100 %)
13 diff
(97.4 %id)
AA476395   .m 2021 to 2273 1 to 253   tiling clone,   253/253
(100 %)
3 diff
(98.9 %id)
CR595077 Neuroblastoma Cot 10-normalized .m 2103 to 3703 1 to 1601   tiling clone,   1601/1601
(100 %)
0 diff
(100 %id)
BM460142 leiomyosarcoma, uterus .m 2125 to 3025 1 to 903       903/1056
(85 %)
17 diff
(98.4 %id)
BG177206 lymph, lymphoma, cell line .m 2165 to 2680 1 to 517       517/519
(99 %)
18 diff
(96.6 %id)
BG257995 embryonal carcinoma, cell line, testis .m 2195 to 2934 1 to 740       740/954
(77 %)
19 diff
(98.1 %id)
AA410676 ovarian tumor, ovary .m 2348 to 2818 1 to 468       468/470
(99 %)
4 diff
(99.2 %id)
TI_149296005   .m 2369 to 3285 987 to 88   AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 900/956
(94 %)
18 diff
(98.2 %id)
TI_154131647   .m 2445 to 3320 926 to 58       869/1077
(80 %)
0 diff
(100 %id)
W02280 liver and spleen .m 2476 to 3070 1 to 598       598/600
(99 %)
10 diff
(98.4 %id)
BG113727 Bone, osteosarcoma, cell line .m 2497 to 3285 1 to 781   AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 781/781
(100 %)
18 diff
(97.7 %id)
BI856623 breast, mammary adenocarcinoma, cell line .m 2498 to 3175 1 to 690       690/826
(83 %)
28 diff
(96.7 %id)
TI_57188573   .m 2498 to 3175 55 to 744       690/826
(83 %)
28 diff
(96.7 %id)
BM462706 melanotic melanoma, skin .m 2508 to 3285 13 to 794       782/798
(97 %)
9 diff
(98.9 %id)
BU684063 lung, Primary Lung Cystic Fibrosis EpithelialCells .m 2513 to 3303 789 to 1       789/793
(99 %)
3 diff
(99.7 %id)
BE782584 eye, retinoblastoma .m 2525 to 3305 1 to 781       781/925
(84 %)
37 diff
(96.0 %id)
BG114288 Bone, osteosarcoma, cell line .m 2548 to 3101 1 to 555       555/555
(100 %)
7 diff
(98.8 %id)
BI333559 cervical carcinoma cell line, cervix .m 2548 to 3359 1 to 810       810/816
(99 %)
24 diff
(97.1 %id)
BM999396 Fibrosarcoma .m 2548 to 3303 756 to 1       756/756
(100 %)
7 diff
(99.1 %id)
BQ109431 cervical carcinoma cell line, cervix .m 2555 to 3206 1 to 652       652/652
(100 %)
9 diff
(98.7 %id)
BM541350 leiomyosarcoma, uterus .m 2562 to 3552 68 to 1070       1003/1077
(93 %)
56 diff
(94.9 %id)
BQ425045 melanotic melanoma, skin .m 2563 to 3308 1 to 746       746/747
(99 %)
3 diff
(99.6 %id)
BF032585 adenocarcinoma, ovary .m 2604 to 3237 1 to 634       634/634
(100 %)
2 diff
(99.7 %id)
BE883696 leiomyosarcoma, uterus .m 2605 to 3301 1 to 700       700/756
(92 %)
15 diff
(98.1 %id)
BQ217316 large cell carcinoma, lung .m 2624 to 3296 1 to 673       673/695
(96 %)
7 diff
(99.0 %id)
CA418134 Bone, Human Chondrosarcoma Cell Line .m 2631 to 3303 674 to 1       674/674
(100 %)
7 diff
(99.0 %id)
CA422164 Bone, Enchondroma cell line .m 2635 to 3303 670 to 1       670/670
(100 %)
4 diff
(99.5 %id)
AV701206 adrenal gland .m 2640 to 3285 1 to 647   AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 647/647
(100 %)
50 diff
(92.3 %id)
CN295846 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .m 2667 to 3148 1 to 482       482/482
(100 %)
2 diff
(99.6 %id)
BG033019 breast, mammary adenocarcinoma, cell line .m 2670 to 3292 13 to 636       624/910
(68 %)
17 diff
(98.2 %id)
BG252801 adenocarcinoma, cell line, Liver .m 2672 to 3293 1 to 626       626/648
(96 %)
16 diff
(97.6 %id)
CF139780 CNCAP(3)T-225 cell line, Prostate .m 2684 to 3103 1 to 420       420/495
(84 %)
9 diff
(98.2 %id)
CB123311 Liver .m 2688 to 3300 613 to 1     Submitted on the opposite strand 613/613
(100 %)
6 diff
(99.1 %id)
BM041046 Kidney, Wilms' tumor, cell line .m 2709 to 3285 1 to 576   AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 576/576
(100 %)
3 diff
(99.5 %id)
BG030552 breast, mammary adenocarcinoma, cell line .m 2717 to 3398 1 to 680       680/947
(71 %)
20 diff
(97.9 %id)
DB380997 placenta .m 2755 to 3285 530 to 1       530/533
(99 %)
22 diff
(95.9 %id)
CB118525 Liver .m 2757 to 3278 522 to 1     Submitted on the opposite strand 522/522
(100 %)
8 diff
(98.5 %id)
AA373097 lung .m 2759 to 3085 1 to 326       326/326
(100 %)
2 diff
(99.4 %id)
BX432926.
matches multiple genes
neuroblastoma, placenta .m 2759 to 3570 844 to 28     This clone was ignored, also hits gene huhare 817/878
(93 %)
0 diff
(100 %id)
BE882045 leiomyosarcoma, uterus .m 2769 to 3290 1 to 519       519/519
(100 %)
6 diff
(98.9 %id)
N41509 melanocyte .m 2779 to 3062 1 to 291       291/291
(100 %)
4 diff
(98.7 %id)
BX389405 Neuroblastoma Cot 10-normalized .m 2794 to 3703 1 to 907       907/907
(100 %)
33 diff
(96.4 %id)
BQ227022 embryonal carcinoma, cell line, testis .m 2794 to 3649 1 to 857       857/857
(100 %)
13 diff
(98.5 %id)
AA826368 Kidney, kidney tumor .m 2796 to 3288 494 to 1       494/494
(100 %)
6 diff
(98.8 %id)
CR626570 Placenta Cot 25-normalized .m 2798 to 3529 1 to 732       732/732
(100 %)
0 diff
(100 %id)
BX347894 Placenta Cot 25-normalized .m 2802 to 3461 1 to 663       663/730
(90 %)
22 diff
(97.0 %id)
BX368777 Placenta Cot 25-normalized .m 2802 to 3645 1 to 841       841/844
(99 %)
23 diff
(97.3 %id)
BX371021 Placenta Cot 25-normalized .m 2802 to 3699 1 to 899       899/927
(96 %)
30 diff
(96.8 %id)
BX379408 Placenta Cot 25-normalized .m 2802 to 3733 1 to 921       921/921
(100 %)
23 diff
(97.6 %id)
BX392654 Placenta Cot 25-normalized .m 2802 to 3719 927 to 4       924/930
(99 %)
0 diff
(100 %id)
BX392072 Neuroblastoma Cot 10-normalized .m 2838 to 3720 898 to 5       894/906
(98 %)
0 diff
(100 %id)
AI696836 adenocarcinoma, Pancreas .m 2843 to 3289 447 to 1       447/447
(100 %)
4 diff
(99.2 %id)
BU940118 mixed (pool of 40 RNAs) .m 2848 to 3384 1 to 539       539/857
(62 %)
20 diff
(97.7 %id)
BF907070 uterus_tumor .m 2865 to 3263 402 to 6     Submitted on the opposite strand 397/402
(98 %)
0 diff
(100 %id)
BG282807 adenocarcinoma, cell line, Prostate .m 2881 to 3490 1 to 617       617/981
(62 %)
34 diff
(96.6 %id)
AA767942 germinal center B cell .m 2885 to 3298 414 to 1       414/414
(100 %)
0 diff
(100 %id)
EL948715 eyeball .m 2906 to 3424 1 to 518       518/518
(100 %)
14 diff
(97.3 %id)
BX432927 neuroblastoma .m 2921 to 3602 684 to 1       684/746
(91 %)
39 diff
(94.8 %id)
AW264342 brain, three pooled meningiomas .m 2921 to 3440 520 to 1       520/520
(100 %)
8 diff
(98.5 %id)
TI_154062155   .m 2932 to 3739 899 to 103   AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 797/966
(82 %)
31 diff
(96.8 %id)
BG292408 bladder, transitional cell papilloma, cell line .m 2962 to 3312 1 to 352       352/968
(36 %)
9 diff
(99.1 %id)
AA476345   .m 2966 to 3291 326 to 1       326/326
(100 %)
1 diff
(99.7 %id)
AI267416 brain, frontal lobe (see description) .m 2971 to 3376 27 to 433       407/433
(93 %)
6 diff
(98.7 %id)
CF129865 Chondrosarcoma Lung Metastasis cell lines, lung .m 2976 to 3440 1 to 465   AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 465/465
(100 %)
1 diff
(99.8 %id)
TI_154191754   .m 2976 to 3440 51 to 515   AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 465/465
(100 %)
1 diff
(99.8 %id)
AA602105   .m 2980 to 3306 7 to 333       327/337
(97 %)
6 diff
(98.3 %id)
AW003594 brain, four pooled pituitary adenomas .m 2981 to 3440 459 to 1       459/459
(100 %)
7 diff
(98.5 %id)
BU902532 leiomyosarcoma, uterus .m 3003 to 3614 171 to 794       624/887
(70 %)
41 diff
(95.4 %id)
AW264245 brain, three pooled meningiomas .m 3006 to 3440 435 to 1       435/439
(99 %)
2 diff
(99.6 %id)
DB577917 hypothalamus .m 3011 to 3728 1 to 718     Submitted on the opposite strand 718/718
(100 %)
1 diff
(99.9 %id)
DB573747 hypothalamus .m 3020 to 3728 1 to 707     Submitted on the opposite strand 707/707
(100 %)
10 diff
(98.6 %id)
BU630240 cell lines, Chondrosarcoma .m 3061 to 3728 686 to 17   AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 670/670
(100 %)
1 diff
(99.9 %id)
DR156079 human embryonic stem cells differentiated toan early endodermal cell type .m 3080 to 3728 1 to 648   AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 648/648
(100 %)
2 diff
(99.7 %id)
N42564 melanocyte .m 3081 to 3278 1 to 198       198/198
(100 %)
0 diff
(100 %id)
CB135106 Liver .m 3083 to 3680 1 to 596       596/596
(100 %)
4 diff
(99.4 %id)
CB159131 Liver .m 3083 to 3679 1 to 595   AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 595/595
(100 %)
4 diff
(99.4 %id)
CA421055 Bone, Enchondroma cell line .m 3097 to 3739 663 to 19   AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 645/645
(100 %)
8 diff
(98.8 %id)
CB132553 Liver .m 3107 to 3679 1 to 567   AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 567/567
(100 %)
5 diff
(99.2 %id)
BX372827 Neuroblastoma Cot 25-normalized .m 3162 to 3728 566 to 1       566/661
(85 %)
27 diff
(96.0 %id)
DB358704 whole embryo, mainly head .m 3173 to 3728 557 to 1       557/557
(100 %)
21 diff
(96.3 %id)
TI_154171525   .m 3212 to 3720 135 to 643   AAA   509/571
(89 %)
20 diff
(96.5 %id)
AV660745 corresponding non cancerous liver tissue .m 3214 to 3638 1 to 426     Submitted on the opposite strand 426/426
(100 %)
1 diff
(99.8 %id)
CK000312 mixed .m 3214 to 3648 1 to 438       438/443
(98 %)
8 diff
(98.2 %id)
BE858199 brain, glioblastoma (pooled) .m 3215 to 3679 465 to 1       465/465
(100 %)
0 diff
(100 %id)
C14644   .m 3227 to 3609 1 to 376       376/422
(89 %)
20 diff
(95.3 %id)
C15066   .m 3227 to 3538 1 to 311       311/313
(99 %)
3 diff
(99.1 %id)
C15538   .m 3227 to 3565 1 to 339       339/339
(100 %)
1 diff
(99.8 %id)
BM724713.
matches multiple genes
eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .m 3234 to 3729 1 to 498   AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base), also hits gene LOC220906 498/502
(99 %)
5 diff
(99.1 %id)
AI091841 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .m 3236 to 3743 506 to 1       506/506
(100 %)
0 diff
(100 %id)
N33531 melanocyte .m 3242 to 3726 488 to 1       488/490
(99 %)
6 diff
(98.8 %id)
DB571387 hypothalamus .m 3256 to 3728 1 to 473     Submitted on the opposite strand 473/473
(100 %)
1 diff
(99.8 %id)
DB347582 liver, tumor tissue .m 3256 to 3728 475 to 1       475/480
(98 %)
2 diff
(99.6 %id)
DB547988 hippocampus .m 3258 to 3727 1 to 470     Submitted on the opposite strand 470/471
(99 %)
2 diff
(99.6 %id)
AI432472 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .m 3272 to 3731 460 to 1       460/460
(100 %)
1 diff
(99.8 %id)
AI057632 parathyroid gland, parathyroid tumor .m 3273 to 3728 468 to 12   AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 457/458
(99 %)
0 diff
(100 %id)
DB574253 hypothalamus .m 3277 to 3728 1 to 454     Submitted on the opposite strand 454/454
(100 %)
2 diff
(99.6 %id)
AI917260 Kidney, renal cell tumor .m 3284 to 3432 149 to 1       149/149
(100 %)
2 diff
(98.7 %id)
AI826802 normal prostate, Prostate .m 3284 to 3720 447 to 9       439/447
(98 %)
0 diff
(100 %id)
BF112220 pooled .m 3284 to 3726 443 to 1       443/443
(100 %)
1 diff
(99.8 %id)
DB372540 placenta .m 3285 to 3728 463 to 23   AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 441/541
(81 %)
0 diff
(100 %id)
AW993703 breast_normal .m 3286 to 3510 230 to 1     Submitted on the opposite strand 230/230
(100 %)
18 diff
(92.2 %id)
AI688017 colon .m 3286 to 3733 448 to 1       448/449
(99 %)
2 diff
(99.6 %id)
AI769231 pooled .m 3286 to 3728 454 to 12   AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 443/444
(99 %)
0 diff
(100 %id)
BM091483 Fetal Pancreas (4 Pooled Donors, 18 - 20weeks, Stratagene #738023) .m 3287 to 3732 446 to 1       446/448
(99 %)
2 diff
(99.6 %id)
AW241278 connective tissue, five pooled sarcomas, including myxoidliposarcoma, solitary fibrous tumor, malignant fibroushistiocytoma, gastrointestinal stromal tumor, andmesothelioma .m 3287 to 3432 146 to 1       146/148
(98 %)
1 diff
(99.4 %id)
DB544817 hippocampus .m 3289 to 3727 1 to 439     Submitted on the opposite strand 439/440
(99 %)
2 diff
(99.6 %id)
AW169060 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .m 3289 to 3432 144 to 1       144/146
(98 %)
1 diff
(99.4 %id)
BE044292 pooled .m 3298 to 3725 430 to 3       428/430
(99 %)
0 diff
(100 %id)
BE714532 head_neck .m 3303 to 3543 245 to 4       242/250
(96 %)
0 diff
(100 %id)
BX483262   .m 3303 to 3733 466 to 36     Submitted on the opposite strand 431/466
(92 %)
1 diff
(99.8 %id)
AI192255 uterus .m 3304 to 3556 253 to 1       253/253
(100 %)
1 diff
(99.7 %id)
AI184487 lung .m 3304 to 3728 425 to 1       425/425
(100 %)
1 diff
(99.8 %id)
BU429224 lymph .m 3305 to 3686 391 to 10     Submitted on the opposite strand 382/393
(97 %)
0 diff
(100 %id)
CA848286 Pancreas, Purified pancreatic islet .m 3307 to 3727 421 to 1       421/421
(100 %)
1 diff
(99.8 %id)
AA631776 breast .m 3308 to 3727 420 to 1       420/420
(100 %)
0 diff
(100 %id)
AI718415 aorta .m 3313 to 3726 414 to 1       414/414
(100 %)
0 diff
(100 %id)
CB119953 Liver .m 3314 to 3721 409 to 1     Submitted on the opposite strand 409/409
(100 %)
4 diff
(99.1 %id)
AI735175 colon .m 3319 to 3686 369 to 3       367/369
(99 %)
0 diff
(100 %id)
AI393658 pooled .m 3322 to 3726 426 to 21   AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 406/408
(99 %)
0 diff
(100 %id)
BP423147 small intestine .m 3328 to 3732 1 to 405     Submitted on the opposite strand 405/405
(100 %)
0 diff
(100 %id)
AA772300 parathyroid gland, parathyroid tumor .m 3341 to 3733 397 to 4       394/397
(99 %)
0 diff
(100 %id)
AA976780 pooled germ cell tumors .m 3345 to 3729 385 to 1       385/385
(100 %)
2 diff
(99.5 %id)
R78382.
matches multiple genes
placenta .m 3348 to 3669 328 to 1     This clone was ignored, also hits gene SIAH1 328/383
(85 %)
11 diff
(97.2 %id)
BF917055 uterus_tumor .m 3353 to 3642 290 to 1     Submitted on the opposite strand 290/308
(94 %)
1 diff
(99.7 %id)
R71641.
matches multiple genes
placenta .m 3353 to 3726 379 to 1     also hits gene klopey 379/389
(97 %)
8 diff
(98.0 %id)
AA897789 pooled .m 3353 to 3728 376 to 1       376/376
(100 %)
1 diff
(99.8 %id)
AI190101 heart .m 3354 to 3733 383 to 4       380/383
(99 %)
0 diff
(100 %id)
AI368520 anaplastic oligodendroglioma, brain .m 3356 to 3682 326 to 1       326/326
(100 %)
4 diff
(98.8 %id)
AI810487 Prostate .m 3359 to 3678 313 to 1       313/317
(98 %)
3 diff
(99.1 %id)
AI435565 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .m 3362 to 3686 328 to 4       325/328
(99 %)
0 diff
(100 %id)
AW001707 Kidney .m 3398 to 3728 345 to 15   AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 331/331
(100 %)
0 diff
(100 %id)
D62496   .m 3401 to 3640 1 to 235       235/235
(100 %)
8 diff
(96.6 %id)
AI708695 aorta .m 3403 to 3726 326 to 3       324/326
(99 %)
0 diff
(100 %id)
BM904489 leiomyosarcoma, uterus .m 3408 to 3736 1 to 330   AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 330/330
(100 %)
6 diff
(98.2 %id)
BI086772 cervix .m 3438 to 3728 1 to 290   AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 290/290
(100 %)
1 diff
(99.7 %id)
BX354035 Neuroblastoma Cot 25-normalized .m 3440 to 3736 1 to 297   fully sequenced,   297/297
(100 %)
0 diff
(100 %id)
AA999734 breast .m 3449 to 3727 278 to 1       278/278
(100 %)
2 diff
(99.3 %id)
N31835 melanocyte .m 3452 to 3743 292 to 1       292/292
(100 %)
1 diff
(99.7 %id)
AA581959 germ cell tumor .m 3453 to 3727 275 to 1       275/275
(100 %)
0 diff
(100 %id)
AA604752 adrenal adenoma, adrenal gland .m 3453 to 3732 280 to 1       280/280
(100 %)
0 diff
(100 %id)
AA737414 germinal center B cell .m 3453 to 3728 286 to 12   AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 275/275
(100 %)
9 diff
(96.8 %id)
AA833881 germinal center B cell .m 3453 to 3733 287 to 6       282/287
(98 %)
0 diff
(100 %id)
AA858211 colon, colon tumor .m 3453 to 3728 287 to 12   AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 276/276
(100 %)
0 diff
(100 %id)
AI279411 borderline ovarian carcinoma, ovary .m 3453 to 3728 289 to 14   AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 276/276
(100 %)
0 diff
(100 %id)
AI469804 colon, moderately-differentiated adenocarcinoma .m 3453 to 3728 289 to 14   AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 276/276
(100 %)
0 diff
(100 %id)
AI799372 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .m 3453 to 3730 278 to 1       278/278
(100 %)
0 diff
(100 %id)
AA643537 colon, colon tumor RER+ .m 3466 to 3578 113 to 1       113/113
(100 %)
1 diff
(99.2 %id)
AA235385 ovarian tumor, ovary .m 3467 to 3726 260 to 1       260/260
(100 %)
0 diff
(100 %id)
BG149221 carcinoid, lung .m 3485 to 3691 72 to 278     Submitted on the opposite strand 207/278
(74 %)
6 diff
(97.9 %id)
AA525255 prostate metastasis, liver .m 3496 to 3715 220 to 1       220/225
(97 %)
2 diff
(99.2 %id)
N74022 liver and spleen .m 3505 to 3728 225 to 1       225/231
(97 %)
2 diff
(99.2 %id)
BG272595 head/neck, nasopharyngeal carcinoma .m 3566 to 3733 169 to 2       168/192
(87 %)
0 diff
(100 %id)
GD138708   .m 3568 to 3733 1 to 166       166/169
(98 %)
3 diff
(98.3 %id)
CN414674 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .m 3569 to 3733 170 to 6     Submitted on the opposite strand 165/170
(97 %)
0 diff
(100 %id)
GD139332   .m 3572 to 3689 7 to 124       118/130
(90 %)
3 diff
(97.7 %id)
BX354034 Neuroblastoma Cot 25-normalized .m 3573 to 3709 137 to 1   fully sequenced,   137/137
(100 %)
0 diff
(100 %id)
AI350059 carcinoid, lung .m 3586 to 4005 1 to 420   tiling clone, Submitted on the opposite strand 420/420
(100 %)
0 diff
(100 %id)
AW515527 lymph node, lymphoma, follicular mixed small and largecell .m 3621 to 3744 124 to 1       124/124
(100 %)
0 diff
(100 %id)
DW428945 Liver .n 1 to 250 274 to 11   tiling clone,   257/274
(93 %)
0 diff
(100 %id)
DA307671 hippocampus .n 1 to 571 2 to 573   capped   572/572
(100 %)
1 diff
(99.9 %id)
BP873519 embryonal kidney .n 4 to 594 1 to 588       588/588
(100 %)
7 diff
(98.9 %id)
DA221066 brain .n 18 to 570 2 to 556   capped   555/555
(100 %)
2 diff
(99.7 %id)
DA850441 placenta .n 24 to 565 2 to 543   capped   542/542
(100 %)
0 diff
(100 %id)
CB156388 brain .n 25 to 627 1 to 604       604/604
(100 %)
3 diff
(99.6 %id)
CD704438 normal nasopharynx .n 25 to 311 15 to 303       289/303
(95 %)
6 diff
(98.1 %id)
DA697414   .n 67 to 635 2 to 570   tiling clone, capped   569/569
(100 %)
1 diff
(99.9 %id)
BQ325150 colon_ins .n 205 to 731 536 to 10       527/536
(98 %)
4 diff
(99.3 %id)
DW416500 Liver .n 255 to 549 18 to 309       295/309
(95 %)
8 diff
(97.5 %id)
CD707181 normal nasopharynx .n 285 to 453 6 to 176       171/176
(97 %)
8 diff
(95.5 %id)
DA277797 corpus callosum .n 290 to 773 2 to 485   capped   484/484
(100 %)
0 diff
(100 %id)
DA762154 tongue .n 290 to 825 2 to 538   capped   537/537
(100 %)
1 diff
(99.9 %id)
DA160633 amygdala .n 294 to 871 2 to 579   capped   578/578
(100 %)
0 diff
(100 %id)
DA706077   .n 294 to 839 2 to 549   capped   548/548
(100 %)
2 diff
(99.7 %id)
AL702877 human skeletal muscle .n 298 to 1050 1 to 754   tiling clone,   754/754
(100 %)
2 diff
(99.8 %id)
DA947455 Spleen .n 300 to 871 2 to 580   capped   579/579
(100 %)
10 diff
(98.3 %id)
DA308868 hippocampus .n 303 to 878 2 to 578   capped   577/577
(100 %)
1 diff
(99.9 %id)
BU662270 blood .n 303 to 952 1 to 649       649/649
(100 %)
1 diff
(99.9 %id)
AK021904 whole embryo, mainly head .n 311 to 2171 1 to 1861 H69R tiling clone, available from FLJ,   1861/1861
(100 %)
10 diff
(99.5 %id)
DA310894 hippocampus .n 312 to 881 2 to 572   capped   571/571
(100 %)
1 diff
(99.9 %id)
DA313097 hippocampus .n 312 to 853 2 to 545   capped   544/544
(100 %)
2 diff
(99.7 %id)
DA439826 tongue, tumor tissue .n 312 to 905 2 to 595   capped   594/594
(100 %)
0 diff
(100 %id)
AU119792 whole embryo, mainly head .n 312 to 1101 2 to 792 H69R tiling clone, capped   791/797
(99 %)
8 diff
(99.0 %id)
DB191823 ovary, tumor tissue .n 312 to 863 2 to 553   capped   552/552
(100 %)
0 diff
(100 %id)
DA191090 amygdala .n 314 to 884 2 to 572   capped   571/571
(100 %)
0 diff
(100 %id)
DA593624 lung .n 314 to 874 2 to 565   capped   564/564
(100 %)
3 diff
(99.5 %id)
DA156834 amygdala .n 315 to 873 2 to 560   capped   559/559
(100 %)
0 diff
(100 %id)
DA717550   .n 315 to 862 2 to 549   capped   548/548
(100 %)
0 diff
(100 %id)
DA727348   .n 315 to 899 2 to 588   capped   587/587
(100 %)
2 diff
(99.7 %id)
DA997069   .n 315 to 849 2 to 536   capped   535/535
(100 %)
0 diff
(100 %id)
CR746990 large cell carcinoma, lung .n 316 to 796 36 to 516       481/516
(93 %)
6 diff
(98.9 %id)
DB130991 thymus .n 316 to 883 2 to 569   capped   568/568
(100 %)
0 diff
(100 %id)
BQ440238 eye, retinoblastoma .n 318 to 616 1 to 302   AAA   302/767
(39 %)
6 diff
(99.3 %id)
BG939203 Bone, Hip .n 326 to 791 8 to 473       466/473
(98 %)
7 diff
(98.6 %id)
CB214987 normal endometrium, late proliferativephase, cycle day 13, uterus .n 332 to 948 1 to 617       617/617
(100 %)
0 diff
(100 %id)
CN333342 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .n 334 to 957 9 to 632       624/632
(98 %)
6 diff
(99.1 %id)
TI_1948230228   .n 474 to 953 608 to 129       480/507
(94 %)
0 diff
(100 %id)
TI_1948230733   .n 480 to 953 600 to 127       474/501
(94 %)
0 diff
(100 %id)
TI_1948230403   .n 490 to 953 593 to 130       464/491
(94 %)
0 diff
(100 %id)
R56382 whole brain .n 660 to 1120 1 to 469       469/469
(100 %)
11 diff
(97.7 %id)
CN333335 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .n 710 to 873 1 to 164       164/164
(100 %)
0 diff
(100 %id)
H40614 brain .n 738 to 925 1 to 191       191/191
(100 %)
3 diff
(98.5 %id)
AA326222 brain, cerebellum .n 1111 to 1399 1 to 290       290/290
(100 %)
1 diff
(99.7 %id)
AI378234 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .n 1131 to 1454 134 to 457   tiling clone, Submitted on the opposite strand 324/457
(70 %)
6 diff
(98.7 %id)
BE253464 eye, retinoblastoma .n 1149 to 1726 1 to 578       578/578
(100 %)
5 diff
(99.2 %id)
CN295847 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .n 1173 to 1743 1 to 571       571/571
(100 %)
2 diff
(99.7 %id)
BE886475 leiomyosarcoma, uterus .n 1176 to 1881 1 to 704       704/906
(77 %)
17 diff
(98.2 %id)
BP428829   .n 1178 to 1571 1 to 394       394/394
(100 %)
5 diff
(98.8 %id)
BP429322   .n 1192 to 1607 1 to 416       416/416
(100 %)
5 diff
(98.8 %id)
BI333373 cervical carcinoma cell line, cervix .n 1197 to 1862 37 to 702       666/702
(94 %)
6 diff
(99.2 %id)
CD690822 normal nasopharynx .n 1206 to 1745 15 to 554       540/554
(97 %)
10 diff
(98.2 %id)
AA121615.
matches multiple genes
brain, neuroepithelial cells .n 1211 to 1741 1 to 537     also hits gene LOC220906 537/539
(99 %)
15 diff
(97.3 %id)
C03656 heart .n 1213 to 1336 9 to 132       124/132
(93 %)
6 diff
(95.5 %id)
AW367703 head_neck .n 1226 to 1504 310 to 34       277/310
(89 %)
0 diff
(100 %id)
BF798985 colon_ins .n 1226 to 1475 254 to 1     Submitted on the opposite strand 254/254
(100 %)
19 diff
(92.6 %id)
BF799032 colon_ins .n 1226 to 1496 287 to 13     Submitted on the opposite strand 275/287
(95 %)
0 diff
(100 %id)
AA343604 gall bladder .n 1234 to 1498 1 to 266       266/266
(100 %)
2 diff
(99.3 %id)
AW579753 head_neck .n 1234 to 1671 8 to 442       435/465
(93 %)
10 diff
(97.9 %id)
AV687973 hepatocellular carcinoma .n 1273 to 1611 1 to 332       332/336
(98 %)
7 diff
(98.0 %id)
BQ631463.
matches multiple genes
Pancreas, Purified pancreatic islet .n 1278 to 1873 1 to 596     also hits gene LOC220906 596/596
(100 %)
4 diff
(99.4 %id)
BQ631681.
matches multiple genes
Pancreas, Purified pancreatic islet .n 1281 to 1889 17 to 625     also hits gene LOC220906 609/625
(97 %)
6 diff
(99.1 %id)
BG025752 lymph, lymphoma, cell line .n 1314 to 1911 1 to 598       598/598
(100 %)
3 diff
(99.5 %id)
AA091276   .n 1325 to 1568 1 to 241       241/241
(100 %)
4 diff
(98.4 %id)
AA364360 pineal body .n 1349 to 1644 1 to 296       296/296
(100 %)
2 diff
(99.4 %id)
BM822006 stomach .n 1438 to 1723 1 to 287       287/287
(100 %)
5 diff
(98.3 %id)
AA353772   .n 1442 to 1641 1 to 200       200/200
(100 %)
1 diff
(99.5 %id)
W46322.
matches multiple genes
senescent fibroblast .n 1448 to 1858 1 to 420     also hits gene LOC220906 420/420
(100 %)
11 diff
(97.4 %id)
BG896859 cartilage .n 1452 to 1766 86 to 400       315/332
(94 %)
8 diff
(97.6 %id)
AU146048 whole embryo, mainly head .n 1644 to 2171 529 to 1       529/538
(98 %)
24 diff
(95.6 %id)
AA302250 aorta .n 1645 to 1884 1 to 240       240/240
(100 %)
0 diff
(100 %id)
AA427968   .o 1 to 453 1 to 452   tiling clone,   452/454
(99 %)
5 diff
(98.9 %id)
AA375413 lung .o 153 to 501 1 to 349   tiling clone,   349/351
(99 %)
11 diff
(96.9 %id)
AA427885   .o 616 to 1051 437 to 2   tiling clone,   436/437
(99 %)
0 diff
(100 %id)
DB043649 testis .p 1 to 592 2 to 596   tiling clone, capped   595/604
(98 %)
5 diff
(99.2 %id)
BU192866 eye, retinoblastoma .p 11 to 837 1 to 835 Y104L R105S E107* tiling clone,   835/860
(97 %)
13 diff
(98.5 %id)
DA687795   .q 1 to 543 2 to 544   tiling clone, capped   543/543
(100 %)
0 diff
(100 %id)
DA954972 Spleen .q 13 to 586 2 to 575   capped   576/574
(100 %)
2 diff
(99.7 %id)
DB281646 uterus .q 13 to 575 2 to 564   capped   563/563
(100 %)
0 diff
(100 %id)
DA725203   .q 16 to 578 2 to 564   capped   563/564
(99 %)
1 diff
(99.9 %id)
CD639721 pooled .q 52 to 775 1 to 722 K97R E98R M99W G100A T101H ... tiling clone,   722/722
(100 %)
10 diff
(98.7 %id)
AW580823 leiomios .r-u 1 to 636 1 to 629 P2L C7Y C10A M11C F12L ... tiling clone,   629/631
(99 %)
15 diff
(97.7 %id)
DA016153 adrenal gland .s 1 to 477 6 to 482 exact tiling clone, capped   481/481
(100 %)
0 diff
(100 %id)
CV338276 amnion_normal .s 152 to 616 23 to 502   tiling clone,   480/502
(95 %)
6 diff
(98.9 %id)
DB147211 thymus .t-u 1 to 569 2 to 570 exact tiling clone, capped   569/569
(100 %)
0 diff
(100 %id)
DA827825 pericardium .t-u 4 to 573 2 to 572 R5L I6D P7S V8C S10L ... capped   571/571
(100 %)
2 diff
(99.7 %id)
DA786127 brain .t-u 16 to 585 2 to 571 exact capped   570/570
(100 %)
1 diff
(99.9 %id)
DB266343 uterus .t-u 18 to 585 2 to 570 V29C A30G E31G E32G G34R ... tiling clone, capped   569/569
(100 %)
4 diff
(99.3 %id)
DA875586 Prostate .u 1 to 575 2 to 576 exact tiling clone, capped   575/575
(100 %)
1 diff
(99.9 %id)
DA875629 Prostate .u 1 to 562 2 to 563 exact tiling clone, capped   562/563
(99 %)
2 diff
(99.7 %id)
DC389942 Spleen .va 1 to 552 1 to 553 exact tiling clone,   553/553
(100 %)
1 diff
(99.9 %id)
DA069739 cerebellum .vb 1 to 495 2 to 497 exact tiling clone, capped   496/496
(100 %)
1 diff
(99.8 %id)
BM828050 Ascites, stomach .vc 1 to 491 1 to 491 exact tiling clone,   491/491
(100 %)
0 diff
(100 %id)
BQ775407 Bone, Human Chondrosarcoma Cell Line Gene RPL7L1, variant not shown         Suspected internal deletion, this clone was ignored    
BU619618 Cell Line, Chondrosarcoma Gene RPL7L1, variant not shown       AAA Submitted on the opposite strand    
AV684843 hepatocellular carcinoma Gene RPL7L1, variant not shown         Suspected internal deletion, this clone was ignored    
AV691169 hepatocellular carcinoma Gene RPL7L1, variant not shown         Suspected internal deletion, this clone was ignored    
T10575   Gene RPL7L1, variant not shown         This clone was ignored    
DB360425 mammary gland Gene RPL7L1, variant not shown              
DA645811 mammary gland Gene RPL7L1, variant not shown       capped      
DB360454 mammary gland Gene RPL7L1, variant not shown       AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base)    
DA645837 mammary gland Gene RPL7L1, variant not shown       capped Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base)    
AK297324 brain Gene RPL7L1, variant not shown              
DA220499 brain Gene RPL7L1, variant not shown       capped      
DC351019 brain Gene RPL7L1, variant not shown              
AI640584 Kidney Gene RPL7L1, variant not shown              
AI890278 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus Gene RPL7L1, variant not shown              
BE613698 leiomyosarcoma, uterus Gene RPL7L1, variant not shown              
TI_1948236604   Gene RPL7L1, variant not shown       AAA      
TI_1948236605   Gene RPL7L1, variant not shown              
TI_1948236808   Gene RPL7L1, variant not shown              
TI_1948236809   Gene RPL7L1, variant not shown              
TI_1948237135   Gene RPL7L1, variant not shown              
TI_1948237136   Gene RPL7L1, variant not shown              
DC410344 thymus Gene RPL7L1, variant not shown         Suspected internal deletion, this clone was ignored    
TI_154170134   Gene RPL7L1, variant not shown         This clone was ignored    
112 other accessions, mainly redundant or of lesser quality, also belong to this gene but are not reported.
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k, .l, .m, .n, .o, .p, .q, .r-u, .s, .t-u, .u, .va, .vb, .vc Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes CI